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Tamica N. Collins  
THE ROLE OF ADAPTOR PROTEINS CRK AND CRKL IN LENS DEVELOPMENT 
 
Cell shape changes and signaling pathways are essential for the development and function 
of the lens.  During lens development proliferating epithelial cells will migrate down to the 
equator of the lens, differentiate into lens fiber cells, and begin to elongate along the lens 
capsule. The Fibroblast Growth Factor (FGF) signaling pathway has been extensively 
studied for its role in lens fiber cell differentiation and elongation. However, the main 
mediators of FGF stimulated lens fiber cell elongation have not been identified. Adaptor 
proteins Crk and CrkL are SH2- and SH3-containing proteins that transduce signals from 
upstream tyrosine phosphorylated proteins to downstream effectors, including Ras, Rac1 
and Rap1, which are important for cell proliferation, adhesion and migration. Underlying 
their diverse function, these two adaptor proteins have been implicated in receptor tyrosine 
kinase signaling, focal adhesion assembly, and cell shape. To explore the role of Crk and 
CrkL in FGF signaling-dependent lens development and fiber elongation, we employed 
Cre/LoxP system to generate a lens specific knockout of Crk/CrkL. This led to extracellular 
matrix defects, disorganization of the lens fiber cells, and a defect in lens fiber cell 
elongation. Deletion of Crk and CrkL in the lens also mitigated the gain-of-function 
phenotype caused by overexpression of FGF3, indicating an epistatic relationship between 
Crk/CrkL and FGF signaling during lens fiber cell elongation. Further studies, revealed 
that the activity of Crk and CrkL in FGF signaling is controlled by the phosphatase Shp2 
and the defect observed in lens fiber cell elongation can be rescued by constitutive 
activation of the GTPases Ras and Rac1 in the Crk and CrkL mutant lens. Interestingly, 
the deletion of the GTPases Rap1 in the lens showed no obvious phenotype pertaining to 
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lens fiber cell elongation. These findings suggest that Crk and CrkL play an important role 
in integrating FGF signaling and mediating lens fiber cell elongation during lens 
development. 
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CHAPTER ONE 
Introduction 
1.1 Eye development  
1.1.1 Overview of murine eye development  
 
The formation of the eye begins during gastrulation, a very early stage of embryonic 
development. Specifically, eye development commences during the development of the 
forebrain with the specification of a single eye field (1). Gastrulation is the formation of a 
three layered structure called the gastrula, consisting of the ectoderm, mesoderm, and 
endoderm (2). Interestingly, only the ectoderm and mesoderm give rise to the important 
structures of the eye. The ectoderm is responsible for the formation of the lens, the cornea 
epithelium, and the eyelid. Also the neuroepithelium, a derivative of the ectoderm, gives 
rise to the retina, the ciliary body, the iris, and the optic nerve. The mesoderm and the 
neural crest subsequently form the extraocular mesenchyme (3).  
 
During the formation of the midline structures of the embryo, the single eye field is 
separated into two distinct sections called the optic vesicles. While the optic vesicle is 
forming, the surface ectoderm begins to thicken and form the lens placode. During 
embryonic day 10, the lens placode comes in contact with the optic vesicle and begins to 
invaginate, forming the lens pit. The optic vesicle also invaginates and becomes the optic 
cup. At approximately embryonic day 11.5, the lens pit closes up to form the lens vesicle 
and the overlying surface ectoderm detaches from the lens vesicle and eventually forms the 
corneal epithelium. Between the stages of embryonic day 12 and 14, the murine lens 
develops into a well-defined structure that consists of a group of mostly quiescent epithelial 
cells at the anterior epithelium layer and a small group of proliferating epithelial cells at 
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the equatorial region that differentiate into lens fiber cells throughout the life of a mouse 
(4).  
 
The optic cup continues to develop with the inner layer of the optic cup becoming the 
neural retina and the outer layer becoming the retinal pigment epithelium (RPE). The 
differentiating cells in the inner layer of the optic cup give rise to multiple cell types such 
as retinal ganglion cells, amacrine cells, bipolar cells, and photoreceptor cells (5). These 
cells are essential for the vision of the mouse and any aberration in their development will 
lead to retinal disorders. The RPE is an extremely important component of the vertebrate 
eye. It is a monolayer of polarized epithelial cells that serve multiple functions such as 
recycling the outer segments of the photoreceptors and maintaining water flow and 
adhesion in the retina (6). During development, the presumptive RPE is surrounded by the 
extraocular mesenchyme constituted by a group of mesodermal and neural crest cells that 
is responsible for regulating differentiation and patterning of the RPE (7). In addition, one 
of the interesting properties of the RPE is its ability to trans-differentiate into the neural 
retina during embryonic development under appropriate stimuli (6,8,8).  
  
 In addition to the neural retina and the RPE, the tip of the optic cup gives rise to the iris 
and the ciliary body. The iris, named after the Greek goddess of the rainbow, is one of the 
most colorful organs in the vertebrate body. The iris is positioned between the corneal 
epithelium and the lens and is important for regulating the amount of light that passes 
through the eye. The development of the iris begins mid-gestation and is solely dependent 
on the proper development of the neuroectoderm, the periocular mesenchyme, and 
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signaling from the developing lens. Made up of multiple cell types, the iris contains three 
major components, the iris pigment epithelium, the iridial muscle, and the iris stroma (9). 
Although the ciliary body and iris are derived from the same embryonic origin, the ciliary 
body is completely different in terms of structure and function. The ciliary body begins as 
the ciliary epithelium and differentiates into two layers, the outer pigmented layer and the 
inner non-pigmented layer. During development of the eye, the ciliary epithelium will fold 
to become the ciliary process and the mesenchyme cells from the neural crest will form the 
connective tissue and ciliary muscle of the ciliary body. In addition, the non-pigment layer 
secretes fibrillins to aid the production of the ciliary zonules. Some of the most important 
roles of the ciliary body is to maintain intraocular pressure, secrete glycoproteins and 
aqueous humor into the vitreous body, and maintain lens shape and structure (10) (11). 
 
After light travels through the components of the eye that were previously discussed, its 
information is sent to the brain as an electrical signal by one of the most important 
components of the eye, the optic nerve. The development of the optic nerve begins at 
embryonic day 11.5 in the mouse and at this stage it is called the optic stalk. During eye 
development, the axons from the ganglion cells travel down toward the optic stalk and 
begin to grow into it to form the optic nerve (5). Once the optic nerve is formed it relays 
visual information to the brain, where it is further processed and perceived.  
 
 
1.1.2 Overview of murine lens development  
 
 Lens development is considered one of the most essential processes in eye development. 
The lens also serves as a great model for molecular and genetics studies and has been used 
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by prominent scientist over the years to explain many developmental processes. One of the 
earliest known studies using the lens was done by Hans Spemann in 1901 in which he 
established the principle of induction. He destroyed the optic vesicle of the frog and found 
that the lens did not form, indicating that the optic vesicle is necessary for lens formation. 
This study paved the way for studies that use the lens as a model to understand 
development.  
 
The development of the mouse lens begins at embryonic day 9 when the head ectoderm 
comes in close contact with an extension of the forebrain, called the optic vesicle (Figure 
1A). This is followed by the thickening of this region of the head ectoderm to form the lens 
placode (Figure 1B). It is now known that development of the lens placode is controlled by 
a plethora of transcription factors such as Pax6, Six3 and Sox2. In addition, the induction 
and inhibition of signaling pathways such as the Bone Morphogenetic Protein (BMP) 
signaling pathway and the Wnt signaling pathway, respectively, play a role in the formation 
of the lens placode (12) (13).  
 
Another important step in lens morphogenesis is the invagination of the lens placode to 
form the lens pit (Figure 1C). The invagination of the lens placode has been extensively 
studied and is regulated by shroom3-mediated apical constriction and a balance between 
Rho GTPases  Rac1 and RhoA that leads to cell shape changes and proper invagination 
(14,15). The lens pit will continue to deepen and the connection between the overlying 
head ectoderm will narrow to form the lens stalk (Figure 1D). The lens vesicle will 
eventually detach from the overlying surface ectoderm and the anterior cells of the lens 
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Figure 1. Lens Development. At mouse embryonic day 9.5 (E9.5), the optic vesicle (OV) 
extends toward the presumptive lens ectoderm (PLE) (Fig. 1A), inducing the latter to 
thicken into a cuboidal layer called a lens placode (Fig. 1B). At E10.5, the lens placode 
invaginates to form a lens pit (Fig. 1C), which eventually closes at the anterior surface to 
form a lens vesicle (Fig. 1D).  Subsequently, the anterior epithelial cells migrate posteriorly 
to the equatorial regions of the lens, where they move inside the lens to elongate into lens 
fiber cells (Fig. 1E and F).  In the mature lens, the lens fiber cells are organized into an 
exquisitely concave pattern to maintain structural integrity and transparency (Fig. 1G) 
(Adapted from Robinson ML)(4). 
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vesicle will become the lens epithelium. The posterior cells of the lens vesicle will 
differentiate into the primary lens fiber cells and fill the lumen of the lens vesicle (Figure 
1F)(4). The primary lens fiber cells will remain in the lens throughout life and are some of 
the oldest cells in the body. As the development of the lens continues, a group of 
proliferating epithelial cells will migrate to the equator of the lens and differentiate into the 
secondary lens fiber cells (Figure 1E). The secondary lens fiber cells will elongate along  
the anterior and posterior axis of the lens. It is important to note that the lens fiber cells 
make up 99 percent of the lens and upon terminal differentiation lens fiber cells undergo 
cytoplasmic organelle degradation.  Also, the synthesis and packing of crystallin protein is 
one of the most important processes of lens development because it creates the 
transparency and refractive medium needed for light to pass through to the retina (16).    
 
1.2 Fibroblast Growth Factor (FGF) signaling pathway 
1.2.1    The Fibroblast Growth Factors 
 
Fibroblast Growth Factors (FGFs) are a group of glycoproteins that control multiple 
developmental processes, during vertebrate and invertebrate development, by binding to 
FGF receptors. FGFs consists of 120-130 amino acids that are organized into 12 
antiparallel β-strands, flanked by a N and C terminal (17). Interestingly, FGF was first 
identified in a bovine pituitary extract, as a protein with fibroblast growth promoting 
activity (18). It was eventually purified in 1983 and was then named basic FGF. Since its 
discovery, 22 members of the FGF family have been identified and can be divided into 
seven subfamilies (19). FGFs can also be characterized based on their signaling 
mechanism, specifically paracrine, intracrine, and endocrine signaling (Figure 2).  
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Figure 2. Evolutionary relationships within the Fgf gene family by phylogenetic 
analysis. Phylogenetic analysis shows that 22 Fgf genes can be arranged into seven 
subfamilies. (Adapted from H.Otha and N.Itoh Human Disorders and the FGF 
Signaling Pathway)  
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Paracrine FGFs bind to FGF receptors and their cofactor heparan sulfate to elicit biological 
responses. Intracrine FGFs differ from paracrine FGFs in that they are not secreted but are 
important for generating action potentials in neurons. 
 
Lastly, Endocrine FGFs are also unique because they are hormone-like, do not require 
heparan sulfates, and utilize a cofactor which belongs to the Klotho family of molecules 
(20). Secreted FGFs (intracrine and paracrine) regulate cellular processes such as 
proliferation, differentiation, migration. Importantly, these FGFs are essential to early 
developmental processes such as differentiation of the inner cell mass, as well as late 
developmental stages such as organogenesis. Endocrine FGFs specifically plays a role in 
regulating various processes in adult organisms such as lipid and carbohydrate metabolism 
(21).    
 
1.2.2 FGF Receptors 
As previously mentioned, FGFs carry out their functions by binding to FGF receptors. FGF 
receptors are a group of tyrosine kinase receptors that are essential for the activation of 
downstream signaling pathways involved in cell proliferation, differentiation, and cell 
growth (22). There are four known FGF receptors (FGFR1-FGFR4); each contains an 
immunoglobulin domain, a transmembrane domain, and a cytoplasmic tyrosine kinase 
domain. Specifically, the immunoglobulin domain consists of approximately 2 to 3 Ig loops 
that occur through alternate splicing and is essential for ligand binding and specificity. The 
first Ig loop is thought to be involved in FGF receptor auto-inhibition and the second and 
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third loops play an important role in FGF binding and the array of ligand binding affinities 
based of the subtypes and isoforms of FGF receptors (23).  In addition, there is a stretch of  
 
amino acids between each Ig I and II loop and a heparin binding domain that is essential 
for increasing the half-life of the FGF and FGF receptor complex (24) .  Lastly, the crystal 
structure of the cytoplasmic tyrosine kinase domain of the FGF receptor reveals an 
activation-loop that contains two tyrosine residues that remains in the inactive or low 
activity do to a kinase invariant proline rich residue at the C-terminal end of the activation 
loop that interferes with substrate binding. Upon activation of the receptor and auto-
phosphorylation of the tyrosine residues signaling proteins are directly recruited to or 
linked to the receptor via docking proteins to induce downstream signaling (19). 
 
 
1.2.3   FGF Signaling  
 
FGF signaling begins by the release of FGF from the extracellular matrix and its binding 
to heparan sulfate proteogylcans (HSPGs), which stabilize the FGF-FGF receptor binding. 
This leads to ligand-dependent dimerization of FGF receptors, which causes a 
conformational change and activation of the tyrosine kinase domain. Subsequent trans-
phosphorylation of tyrosine residues on the FGF receptor creates docking sites for multiple 
adaptor protein such as FGFR substrate 2 (FRS2) and PLCγ1. Extensively studied for its 
role in FGF signaling, FRS2 is known as the main mediator of FGF signaling. FRS2 can 
be phosphorylated by the FGF receptor on multiple sites, which can then interact with 
multiple proteins, leading to important downstream signaling (25).  
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One of the most well established signaling pathways mediated by FRS2 is the MAPK 
signaling pathway. In MAPK signaling, phosphorylated FRS2 recruits son of sevenless 
(SOS) and Growth-factor receptor bound protein 2 (GRB2). SOS is a guanine nucleotide 
exchange factor (GEF) that activates the Ras GTPase. Ras will then stimulate the Raf-to-
MEK-to-ERK pathway. The phosphorylation of ERK leads to activation of transcription 
factors that induce multiple cellular processes such as proliferation and differentiation (26). 
Although the MAPK signaling pathway is one of the main pathways activated by FGF, 
other pathways such as the PI3K-AKT pathway, Phospholipase C pathway, and the STAT3 
pathway can also be activated. In addition, the FGF signaling pathway can be regulated by 
multiple negative regulators such as SEF, FGFR like 1, and Sprouty (25).  
 
1.3   Human Disorders and the FGF Signaling Pathway 
The FGF signaling pathway is one of the crucial signaling mechanisms during embryonic 
development (27). Many developmental diseases are associated with the abnormal function 
of the FGF signaling pathways. In particular, FGF signaling plays a major role in skeletal 
diseases such as dwarfing chondrodysplasias and Craniosynostosis. Dwarfing 
chondrodysplasia is a skeletal disorder that causes abnormal formation of bone. There are 
multiple types of chondrodysplasia such as achondrodysplasia, hypochondrodysplasia, and 
thanatophoric dysplasia that are caused by mutations in the tyrosine kinase domain of FGF 
receptors. Specifically, most of these mutations are caused by mutations in FGF receptor 
3, including the G380R mutation underlying achondroplasia and dwarfism. FGF18 and 
FGF2 are also possible candidates for some of the causes of chondrodysplasias (28).  
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Craniosynostosis is also a disorder of skeletal development and was discovered in 1830 as 
premature fusion of the cranial sutures. It can further be divided into the fusion of one 
suture or the fusion of multiple sutures and characterized as primary or secondary 
craniosynostosis. Primary being that the disorder was caused by a biological event and 
secondary meaning there was some type of external force that caused premature fusion. 
Craniosynostosis occurs in 1 of 2500 live births.  Although most craniosynostosis cases are 
sporadic, there are some syndromic cases, which are due to genetics or specifically 
autosomal dominant inheritance caused by a gain of function mutation in the FGF receptor. 
Most of the time, the gain of function mutation is in the region of the FGF receptor that 
regulates the binding affinity of the FGF ligand to the FGF receptor. This gain of function 
mutation can increase the receptors binding affinity leading to enhanced sensitivity to FGF 
signal, perturbing developmental processes like cell differentiation (29).  
 
There are multiple syndromes associated with craniosynostosis such as Pfeiffer syndrome 
and Crouzon syndrome. Pfeiffer Syndrome is one of the most common syndromes that are 
associated with craniosynostosis, partial syndactyl and midface hypoplasia. Pfeiffer 
syndrome is caused by mutations in both FGF receptors 1 and 2. The mutations in FGF 
receptor 1 are in the linker region between the second and third domain. In contrast, FGF 
receptor 2 mutations are in the Ig III and tyrosine kinase domains (30). Crouzon syndrome 
unlike Pfeiffer syndrome mainly has mutations on FGF receptor 2. The chromosome 
mapping of Crouzon syndrome revealed that it is located in chromosome 10q25-q26. In a 
search for possible genes that can cause Crouzon syndrome, FGF receptor 2 was a possible 
candidate because it was also mapped to chromosome 10q25-q26 (31). This mutation in 
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FGF receptor 2 causes a ligand-independent activation and disrupts ligand binding (32). 
Unlike patients with Pfeiffer syndrome, patients with Crouzon syndrome have normal 
intelligence and normal extremities but exhibit abnormal protrusions of the eye ball and 
jaw (29).  
 
In addition to extensive studies done on FGF signaling and its role in development and 
developmental disease, there is a plethora of studies addressing FGF signaling in cancer. 
The pathogenic outcome of FGF signaling can be caused by distinct alterations in either 
the FGF ligand or the FGF receptor. One of the most common alterations in FGF signaling 
is in the FGF receptor, leading to ligand-independent signaling. It is characterized by 
activation mutations, chromosomal translocation, and receptor gene amplification. Bladder 
cancer has been most frequently linked to FGF receptor mutations. Specifically, 
approximately 50 percent of bladders cancers are caused by mutations in FGF receptor 3 
and most mutations are seen in the transmembrane domain. Hematological malignancies 
are another example of how FGF signaling is linked to cancer. They can be caused by 
chromosomal translocation of the FGF receptor, which creates a fusion protein that 
contains an N terminus of a transcription factor fused with a FGF receptor kinase domain. 
This leads to constant FGF receptor dimerization and a constitutively active FGF receptor. 
In addition to chromosomal translocation, gene amplification has been shown to play a 
significant role in cancer. Gene amplification in FGF receptor 1 and 2 has been implicated 
in certain cancers like gastric cancer and breast cancer. In breast cancer, amplification of 
the FGF receptor 1 chromosomal region 8p11-12 is a very common focal amplification, 
especially in Estrogen Receptor positive breast cancers (25).  
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Although mutations in the FGF receptor are the most common mutations seen in cancers, 
there are some mutations found in the FGF ligand that can also lead to cancer. Somatic 
mutations in FGF9 has been known to cause colorectal and endometrial cancer (33).  In 
addition, overproduction of autocrine FGF has been seen in many types of tumors. The 
upregulation of multiple FGFs such as FGF 2, FGF 8, and FGF 18 is known to be involved 
in cell survival and neovascularization. Similar to autocrine FGFs, paracrine FGFs has also 
been reported in many cancers. Other examples included the overexpression of serum 
FGF2 which is associated with small-cell lung cancer and poor prognosis (34).  
 
1.4 FGF Signaling and Eye Development 
1.4.1 FGF Signaling and Lens Development 
As previously discussed, FGF signaling plays an extensive role in embryonic development, 
particularly in lens development. It has been reported that in the presence of a FGF receptor 
inhibitor, there was a reduction of Pax6, a prominent marker of lens induction. Similarly, 
after expression of a truncated FGF receptor, lens development was perturbed as early as 
the lens induction stage (35). In addition examination of embryos, containing lens Cre 
conditional knockout of FGF receptor 1 and 2 ,displayed a thin lens placode and an increase 
in the TUNEL labeling index at embryonic day 9 compared to wild type litter mates (36). 
Taken together these data reveal how essential FGF signaling is for lens induction.  
 
It has also been established that lens epithelial cell proliferation is regulated by growth 
factors, such as FGFs, in the aqueous humour of the eye. In vitro and in vivo studies have 
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also revealed that there is a gradient of FGF present in the lens that establish polarity and 
induces different cellular response, such as cell proliferation. This gradient was first 
observed by McAvoy and Chamberlin in 1989 using rat lens explants. They found that as 
you increase the concentration of FGF, cell proliferation occurs first but as you continue to  
increase the concentration cell elongation and differentiation follows (37). Using a 
thymidine incorporation assay and a cell labeling method on lens epithelial cells, it was 
shown that as the concentration of basic FGF increased the first cellular response was cell 
proliferation (38). More recent studies have found that in the presence of a low dose of 
FGF, lens explants displayed increased Erk activity compared to wild type and an increase 
in the amount of Brdu incorporated cells compared to explants treated with the MEK 
inhibitor UO126. The discovery that there is a gradient of FGF present in the lens has been 
a landmark in understanding the role of FGF signaling (Figure 3) (39).  
 
From this discovery, the role of FGF signaling in lens cell differentiation was further 
characterized by using a dominant negative form of FGF receptor 1. Transgenic mice with 
the dominant negative receptor 1 exhibited a reduction in the cell differentiation process 
and an increase in cellular apoptosis (40). It was also found that the lens epithelial cells in 
FGF receptor 2 knock out mice fail to exit the cell cycle indicated by a decrease in cell 
cycle inhibitors like p27kip1 (41). In addition, FGF receptor 1, 2, and 3 can compensate for 
each other during lens fiber cell differentiation, indicated by the more severe phenotypes 
when all three receptors are deleted (42).  
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Studies displaying ectopic and overexpression of FGFs also revealed important roles of 
FGF signaling during lens development. Transgenic expression of  a human FGF-1, using 
a Aα-crystallin promoter for expression in the ocular lens, induced lens fiber cell 
elongation and expressed β-crystallin (43).To further understand the role of FGFs in lens 
development, transgenic expression of a secreted from of FGF3 in the ocular  lens using 
the same Aα-crystallin promoter caused differentiation of the entire lens epithelium and 
subsequently lead to degeneration of the lens (44).  These studies further confirmed one of 
the crucial roles of FGF signaling in lens development is lens fiber cell elongation and 
differentiation.  
   
Lastly, recent studies have delved into the co-factors and downstream proteins that are 
essential for FGF-mediated lens fiber cell differentiation, which include heparan sulfates, 
the adaptor protein Frs2, and the phosphatase Shp2. Disruption of heparan sulfates prevents 
lens fiber cell differentiation shown by a decrease in differentiation markers and an increase 
in the lens epithelial cell marker E-cadherin (46). Similarly, conditional knockout of Frs2 
in the mouse lens leads to decrease in lens differentiation markers, Prox1 and β- crystallin 
(47). The genetic interaction of Frs2 and Shp2 has been shown to be essential for FGF-
mediated lens fiber cell differentiation in that it completely abolishes lens development by 
as early as embryonic day 12.5 (48).  
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Figure 3. Gradient of FGF stimulation in lens cell behavior. The gradient of FGF 
establishes the cellular response needed for the development of the lens. As FGF signaling 
increases along the anterior to posterior axis of the lens, a transition from cell proliferation 
to differentiation is induced. (Adapted from F.J. Lovicu and J.W. McAvoy (45)) . 
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1.4.2 The FGF Signaling Pathways and Diseases of the Eye 
   FGF signaling has been implicated in some eye disorders such as ocular coloboma. 
Ocular coloboma is caused the failure of the optic vesicle fissure to close properly and can 
affect multiple components of the eye including the lens, retina, and the optic nerve. Ocular 
coloboma is known to be one of the most common eye disorder in children that causes 
visual impairment and blindness (49).  Recent studies have found that conditional deletion 
of FGF receptors 1 and 2 in the optic vesicle of the mouse leads to ocular coloboma and 
optic nerve dysgenesis, indicating the importance of FGF signaling in eye development and 
disease.  Another disease caused by mutations in FGF or its FGF receptor is the Lacrimo-
auriculo-dento-digital (LADD) syndrome with lacrimal duct aplasia being is one of the 
main features. Mutations in the tyrosine kinase domain of the genes encoding FGF receptor 
2 or 3 and in the ligand FGF 10 has been implicated in this disease (50). Lastly, loss of the 
FGF receptor and downstream effectors in the FGF signaling pathway during mouse eye 
development lead to microphthalmia and anophthalmia, indicating that loss of FGF 
signaling is crucial during mammalian eye development (51).  
 
1.5 FGF Adaptor Proteins Crk and CrkL  
1.5.1 Overview of FGF Adaptor Proteins Crk and CrkL  
In the late 1980s, Bruce Mayer discovered a novel oncogene derived from a chicken tumor 
sample. Interestingly, Mayer and his colleagues also found that this novel oncogene did 
not contain a catalytic domain but was a fusion gene that consisted of a retroviral gene 
encoding the protein gag and a cellular gene that encoded for SH2 and SH3 domains. 
Characterized with no catalytic activity, this viral oncogene was surprisingly able to 
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dramatically increase tyrosine phosphorylation of proteins in transformed chicken embryo 
fibroblast cells. This unique feature led to the idea that this novel viral oncogene could 
mediate tyrosine kinase activity hence its name, Crk (Chicken tumor virus No. 10 [CT-10] 
regulator of kinase) (52) .  
 
Since the discovery of viral (v)-Crk, due to alternative splicing at a single gene locus, two 
species CrkI and CrkII have been identified in mammalian cells (Figure 4). Although these 
two species are homologs of v-Crk, they differ in their oncogenic activity. CrkI has 
significantly more transforming activity than CrkII and is similar to the oncogenic tyrosine 
kinases such as Src. The decrease in transforming activity in CrkII is attributed to the 
phosphorylation of tyrosine residue at 221, a feature that is absent in CrkI (Figure 4). In 
particular, the phosphorylation of tyrosine 221 leads to its intramolecular binding to the 
SH2 domain, which sequesters the SH2 and SH3 domains of CrkII, preventing binding of 
target proteins (53). 
 
Another gene was also cloned by Hoeve et al., with the goal of identifying genes located 
near the BCR gene on chromosome 22. The exons at this cloned location encoded for a   
SH2 domain, which gives some insight on the role of this gene. Eventually, the complete 
cDNA sequencing was done and it revealed a novel Crk like (CrkL) gene. The CrkL protein 
has 60% homology to CrkII and is quite similar in biological function and post-translational 
modifications. For example, CrkL phosphorylation at tyrosine 207 also causes intra-
molecular binding and sequesteration of the SH2 and SH3 domain (Figure 4) (53,54). 
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Figure 4. Structure of the Crk family of proteins.  All Crk family adaptor proteins are 
comprised of SH2 and SH3 domains. The domains are boxed: SH2, Src homology 2; SH3, 
Src homology 3; Gag, viral group specific antigen; Y221 or Y207, negative regulatory 
phosphorylation site. Adapted from Birge et al (46). 
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All the members of the Crk family carry out their function through their SH2 and SH3 
domain. Specifically, to transduce intracellular signaling, Crk acts as a molecular switch 
by binding to phosphotyrosine residues via its SH2 domain and interacting with proline 
rich regions of other proteins via its SH3 domain. The first protein that was identified as 
interacting with the SH2 domain of Crk was paxillin.  Paxillin is a substrate for multiple 
tyrosine kinases such as Src.  It can bind to the focal adhesion kinase (FAK) and form 
complexes with Crk, leading to downstream signaling.  
 
Shortly after the discovery of paxillin, a 130 KDa protein was cloned as a Crk associated 
tyrosine kinase substrate and thus named p130Cas. It has been well established that 
p130cas is a part of an important group of multi-site docking and scaffolding proteins. 
After phosphorylation of p130Cas, Crk and CrkL specifically bind to p130Cas via its SH2 
domain. As its name implies, p130cas then becomes a substrate for tyrosine kinases and 
can be phosphorylated by tyrosine kinases such as Src. Specifically, phosphorylation of 
p130cas by Src leads to the assembly of a p130cas-Crk-Dock180 protein complex 
important for lamellipodia formation and cell migration. The phosphorylation of p130cas 
can also be induced by mechanical stretch, leading to the binding of Crk and activation of 
the GTPase Rap1 (55,56).  
 
In addition to the SH2 domain, the family of Crk adaptor proteins will employ their SH3 
domain to activate effector proteins such as guanine nucleotide exchange factors (GEFs) 
and kinases to induce downstream signaling. One of the first proteins known to bind to the 
SH3 domain of Crk is the GEF C3G. The activation of C3G occurs through its recruitment 
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to the membrane by Crk and phosphorylation on tyrosine 504, leading to repression of a 
cis-acting negative regulatory domain outside of the catalytic domain (57). Once activated, 
C3G is responsible for catalyzing the dissociation of GDP from the GTPase Rap1, allowing 
a GTP molecule to enter and bind in its place. The binding of a GTP to Rap1 leads to its 
activation, which promotes cell adhesion and cell spreading (58).  
 
Another GEF that binds to the SH3 domain of Crk and induce downstream signaling is 
Dock180. The family of Dock180 proteins is unique in that, unlike other GEFs, it does not 
have a catalytic domain but contains a conserved domain named the “Docker” domain. 
This domain binds to Rho GTPases and is necessary for the nucleotide exchange of Rho 
GTPases such as Rac. Also the binding of Dock180 to Rac requires association of the 
protein ELMO to Dock180 SH3 domain. How ELMO aids Dock180 in Rac activation 
hasn’t been fully established, but it can be summarized into three mechanisms. It is first 
proposed that ELMO helps Dock180 stabilize Rac through its PH domain. It was also 
established that ELMO prevents the auto-inhibition of Dock180 caused by the binding of 
the SH3 domain to the “Docker” domain. Lastly, studies have found that the Armadillo 
repeats in ELMO can guide the Dock180-ELMO complex to the plasma membrane through 
interaction with active RhoG. Regardless of how the Dock180-ELMO complex comes in 
contact with Rac1, it will eventually cause activation of Rac1 by the replacement of a GDP 
by a GTP molecule. After activation, Rac1 will interact with important downstream 
effectors that are essential for cell proliferation, cell differentiation, and actin cytoskeleton 
reorganization (59). 
  
  
22 
As previously mentioned, the SH3 domain of Crk can interact with tyrosine kinases. One 
of the well-known kinases that bind to the SH3 domain of Crk is Abl (Abelson murine 
leukemia) kinase. ABL was discovered as an oncogene that forms a fusion gene with the 
Breakpoint Cluster Region (BCR) gene. This fusion gene is responsible for the well-
characterized human chronic myelogenous leukemia (CML). Although the function of Abl 
has been primarily studied for its oncogenic activity, it does play a role in multiple cellular 
events such as actin remodeling and cell adhesion. The binding of Abl to the SH3 domain 
of Crk and CrkL leads to their phosphorylation which inhibits binding to p130cas and 
prevents cell migration (60,61). Studies have shown that the lack of phosphorylation of 
CrkI by Abl is responsible for its transformation activity due to the absence of the Y221 
regulatory site found in CrkII. However, recent studies have found that this is only true for 
CML, but in other cancer related diseases, inhibition of Abl can increase the transformation 
activity of CrkI. Therefore, the role of Abl in Crk is extremely important but is 
controversial in its ability to promote or inhibit Crk transformation activity (62).  
 
With its SH2 and SH3 domains, Crk is widely known for its contribution to the integrin 
signaling pathway. Integrins are a family of transmembrane receptors that mediate cell 
adhesion, tissue maintenance and repair, and host defense. Integrin is also responsible for 
relaying signals to control multiple cellular processes such as cell proliferation, survival, 
and cell migration. This type of signaling is called outside-in signaling. Integrin can also 
alter its affinity for ligands by undergoing a conformational change in response to signaling 
from inside of the cell.  This is considered inside-out signaling. Both outside-in and inside-
out signaling mechanisms are extremely important in integrins’ ability to regulate cellular 
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activity. With respect to integrin inside-out signaling, activation of integrin mainly occurs 
when talin binds to the integrin tail. This leads to a conformational change which will 
increase integrin’s affinity for its ligand. The binding of the ligand to integrin forms an 
initial connection between the cytoskeleton and the extracellular matrix in nascent 
adhesions. On the other hand, mature adhesions consist of complex assembly of multiple 
proteins at the cytoplasmic side of integrin that strengthen the connection of integrin to the 
actin cytoskeleton. These multi-protein complexes also transmit signals to the inside of the 
cells to activate kinases such as the Focal adhesion kinases (FAK). FAK can be 
phosphorylated by the Src-family protein kinases to recruit paxillin or p130cas. As 
discussed earlier, paxillin or p130cas have motifs that attract binding of the SH2 domain 
of Crk, which leads to downstream signaling.   
 
1.5.2 The Role of Crk and CrkL in Embryonic Development 
Both Crk and CrkL play multiple roles in embryonic development, which have been 
revealed with the use of mouse genetics. Global knock-out of CrkL in the mouse cause 
defects in cranial and cardiac neural crest derivatives such as the aortic arch arteries, the 
cardiac outflow tract, and the thymus. These mice generally do not survive embryogenesis 
and Crk cannot compensate for this severe phenotype (63). Conditional deletion of both 
CrkI and CrkII using the Cre–Loxp system revealed a variety of phenotypes. One of the 
most obvious phenotypes in the Crk-null embryo at E13.5 was focal and hemorrhagic 
edema on the snout and nasion. The heart of crk null embryos showed multiple 
abnormalties, displaying a thin muscular wall in the heart, and a decrease in the tightly 
packed cells causing the heart to appear extremely dilated. Due to the obvious blood loss, 
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these embryos had ruptured blood vessels and defects in vascular smooth muscle cells. The 
defects in smooth muscles cell, indicated by the loss of smooth muscle actin, can inhibit 
their ability to support blood vessels. Crk null embryos also had defects in nasal 
development and appeared to have a cleft palate. These observations underscore the 
importance and distinct roles of both Crk and CrkL in embryonic development (64).  
 
Crk and CrkL support embryonic development mainly through their ability to maintain cell 
shape and motility. To fully understand this, studies have been done using Cre-loxp 
systems to conditionally delete Crk and CrkL in fibroblast cells to observe their function 
on a cellular level. Crk and CrkL deletion in fibroblast cells reduced cell motility and 
caused loss of focal adhesions. Further observations also showed that Crk and CrkL are 
responsible for the integrity of the cytoskeleton. These finding indicate the importance of 
Crk and CrkL in embryonic development through their ability to mediate important 
biological processes (65).   
 
1.5.3 Crk and CrkL in FGF Signaling  
There are only a few proteins that can directly engage with active FGF receptors such as 
Grb14, Shb, PLCγ, Frs2, Shp2, and Crk (Figure 5.) (66,67). Multiple studies have been 
done to investigate the interaction between the Crk family proteins and the FGF receptors. 
For example, using Primary Aortic Endothelial (PAE) cells, Larsson et. al., showed that 
cells transfected with a chimeric Y463F receptor did not pull down Crk during 
immunoprecipation as untransfected cells do and phosphorylation of mutant FGF receptor 
was lost as indicated using phospho-tyrosine antibodies. The chimeric Y463F receptor also  
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Figure 5. Schematic outline of FGFR-1 signaling transduction molecules. The 
dimerization and trans-phsophorylation FGFR-1 can associate with moleules through 
multiple tyrosine phosphorylation sites. The activation of Crk and PLC-gamma and 
downstream signaling transduction depends on Tyr463 and Tyr766, respectfully. The 
activated FGF can also interact with membrane bound molecules such as FRS2 and the Src 
family tyrosine kinases. Other molecules that are not anchored to the membrane include 
Shc, SHP-2, Shb, and 80 KH. Adapted from Peter Klint and Lena Claesson-Welsh (60).  
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caused a decrease in downstream effectors of the FGF signaling like Erk2 and JUN kinase.  
Furthermore, to show that Crk phosphorylation is solely controlled by FGF receptor 1, PAE 
cells expressing FGF receptor 1 were treated with FGF2 for 7 minutes, which resulted in a 
remarkable increase in tyrosine phosphorylation of Crk as compared to untreated. Taken 
together, it was concluded that the interaction between Crk and the phosphotyrosine 463 
on FGF receptor 1 is responsible for endothelial cell proliferation (68).  
 
The SH3 domain of CrkL can also interact with FGF receptors to induce downstream 
signaling. This was shown in a study in which deletion of both FGF8 and CrkL in mice led 
to severe defects in Cardiovascular, Pharyngeal, and Skeletal development compared to 
deletion of either FGF8 or CrkL alone. Loss of both FGF8 and CrkL also caused a decrease 
in cell survival in neural crest cells needed for development of the OFT septum and 
pharyngeal glands. In-vitro studies using mouse embryonic fibroblast cells showed an 
increase in FGF receptor 1 and 2 phosphorylation when stimulated with FGF8 and direct 
binding of both receptors to CrkL (69). Later studies showed direct binding of CrkL to 
tyrosine 463 of FGF receptor 1 by Molecular dynamic simulation and saturation binding 
experiment. Importantly, FGF8 induces a CrkL-dependent pathway that activates the 
GTPases Rac and Cdc42, which acts as a feed-forward loop leading to activation of MAP 
kinase (Figure 6) (70). There has also been a recently discovered role of CrkL in interacting 
with Sprouty2 to mediate FGF signaling. Sprouty2 binds to CrkL in response to FGF 
stimulation and tyrosine phosphorylation. The SH2 domain and the N terminal SH3 domain 
of CrkL are required for its binding to Sprouty2 and due to the negative regulatory nature 
of Sprouty2 it was thought to suppress CrkL-dependent Rap1 activity (71).   
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1.5.4 Human Disorders Associated with Adaptor Proteins Crk and CrkL  
Consistent with the role of Abl kinase in the transformation activity of Crk, the family of 
Crk proteins plays a role in multiple human disorders. Apart from its role in hematopoietic 
cancers, Crk is also implicated in breast and lung cancer. Crk proteins are involved in 
multiple cell signaling pathways such as EGF and Integrin pathways that are known to be 
involved in breast cancer progression. Microarray analysis of breast cancer tumor samples 
revealed increased levels of CrkI/II and CrkL in high-grade tumors. In addition, increased 
cell proliferation correlated well with increased levels of Crk in high-grade tumors and 
triple negative breast cancers.  Conversely, knockdown of Crk I/II and CrkL decreased cell 
proliferation and tumor growth in metastatic breast cancer. It has recently been concluded 
that the role of Crk in breast cancer is to enhance the response to oncogenic signal in the 
mammary gland. The cellular mechanisms behind this have not been full elucidated. 
However, it is known that Crk is required for elevated phosphorylation of p130cas in basal 
breast cancer cell line and in breast cancer tumor tissues (72). 
 
Similar to breast cancer, elevated levels of CrkI and CrkII correlates with lung 
adenocarcinomas. In particularly, increased levels of Crk are associated with stage III lung 
cancer and more invasive tumors. Also, phosphorylation of tyrosine 221 in Crk is highly 
elevated in lung tumors versus normal lung tissue with the phosphorylation of Crk II being 
more elevated in poorly differentiated tumors. Using a cDNA microarray-based genomic 
profiling analysis of lung cancer cell lines and tumors, the CrkL loci was identified to be 
the most frequently amplified in cancer patients. Consistent with this finding, knockdown 
of CrkL in lung cancer decreased cell cycle progression, survival, and motility, all 
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hallmarks of lung tumors. Future studies are needed to understand the specificity of  Crk 
and CrkL in lung tumors and how crosstalk between these two proteins may cause a more 
severe phenotype (73).   
 
Although the families of Crk proteins are prominent in multiple cancers, it also plays a role 
in the manifestation of other disease such as DiGeorge Syndrome. DiGeorge syndrome is 
a developmental disease caused by deletion on chromosome 22 (del22q11). This particular 
locus is the location of the Crkl gene and 90 % of patients with Digeorge syndrome present 
with this locus deleted. Patients with DiGeorge syndrome exhibit congenital heart disease, 
delayed speech, immune disorders, etc. Partial DiGeorge syndrome can also present in 
many patients with multiple clinical abnormalities and a slight defect in T lymphocytes. It 
was found that expression of CrkL, phosphorylated CrkL, and cell proliferation were 
decreased in the T cells of patients with partial Digeorge syndrome. This revealed a 
mechanism for how CrkL may contribute to the phenotype of patients with partial 
DiGeorge syndrome (74). 
 
1.6 Elongation  
1.6.1 Cell Shape and Function  
 The shape of a cell is essential to its function in both eukaryotic and prokaryotic cell types. 
In prokaryotes, cell shape is actually important for the description and classification of 
bacterial species. Examples of this would be the bacteria spirochete which has a spiral 
shape. For years, the mechanism behind how cell shape changes occuring in bacteria has 
not been well understood. However, some recent studies are starting to open doors into the 
mechanism behind cell shape. It was always clear that the bacterial cell walls and the  
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 Figure 6.  Model of the network that activates the MAP kinase by FGF8. This figure 
illustrates the role of Crkl in a FGF8 mediated feed forward loop that requires its interaction 
with FGF receptors 1/2 leading to MAPK activation through Rac1, cdc42, and PAK. Cell 
adhesion is responsible for creating conditions for cells to respond to growth factors. In the 
presences of FGF8 Crkl can bypass cell adhesion and create similar conditions for cells to 
respond to growth factors. Adapted from Imamoto et al. (70). 
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peptidoglycans that constitute the cell wall are important for maintaining the cell shape. 
More recent genetic studies revealed multiple genes that are important for the rod-shape of 
E. coli or Bacillus Subtilis such as mre genes and rodA. Consistent with the fact that 
peptidoglycan is necessary for cell shape, a lot of the genes discovered are involved in 
peptidoglycan synthesis (75). Lastly, an intermediate filament-like protein called 
Crestcentin formed a filamentous sheath along the curvature of the cell. This was the first 
real evidence that bacteria have a form of a cytoskeleton (76).  
 
Unlike prokaryotes, it is well established that eukaryotes have a cytoskeleton that contains 
actin microfilaments, intermediate filaments, and microtubules that are necessary for 
various cell shapes.  It was also established that focal adhesion assembly is another 
essential component for cell shape. For mouse embryonic carcinoma cells that lack 
vinculin, a cytoskeleton protein, cell spreading was inhibited when they are plated on a 
extracellular matrix (77). Similar to vinculin loss, FAK also had an effect on cell spreading 
and appears to be controlling this via the Integrin pathway (78). Therefore, cell shape is 
the balance between the forces exerted from the intracellular components of the cell and 
the outside environment.   
  
In eukaryotic cells, cell shape changes are essential for development of multiple tissues 
and organs. One of the most prominent events mediated by cell shape change is ventral 
furrow formation during Drosophila gastrulation that involves a coordinated apical 
constriction of progenitors cells located at the ventral-most side of the embryo. Apical 
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constriction is a form of cell shape change that occurs by pulse contraction of the 
actomyosin cortical network on the apical side of the mesoderm progenitors (79).  Another 
important biological activity supported by cell shape is development of the epithelia. 
Epithelial cells maintain various cell shapes such as columnar, cuboidal, and squamous to 
carry out biological functions like secretion and protection. The cell shapes changes that 
occur during development of the epithelia are influenced by cell-behavior, mechanical, and 
molecular factors. For example, the growth of the cell surface of epithelial layers causes 
the cells to have more of a columnar shape whereas volume reduction due to asymmetric 
divisions changes the shape into a more squamous morphology. Although research has 
been done on the cell shape of the epithelia, it is still unclear how the individual factors 
above come together to form different epithelial shapes (80).  
 
Angiogenesis or formation a new blood a cell is another process that is mediated by the 
cell shapes changes. Interestingly, the cell shape changes in endothelial cells can result in 
different response to growth factors.  For example, when endothelial cell spreading is 
limited, treatment with bFGF cause cell differentiation. In contrast, with increasing 
endothelial cells spreading, bFGF elicits a more mitogenic response and promotes DNA 
synthesis. Therefore, the mechanical forces shaping a cell can influence its response to 
cytokines and growth factors (81).  
 
1.6.2   Cell Elongation    
The process of cell elongation was first established in plant growth and development. Cell 
elongation in plants appears as early as germination when seed cells extend in the axial 
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length of the seed, which is needed for disruption of seed coating. The next step in plant 
growth where elongation is important is in the elongation of the stem to the surface to reach 
the source of light. Cell elongation also plays a key role in root expansion, specifically in 
the lengthening of the root and the elongation of the root hairs necessary for absorption of 
water. Lastly, elongation is also important for reproductive development of the plant. A 
great example of this is the apical growth of the pollen tube which elongates so that it can 
penetrate the style after pollination (82).  
 
Elongation is also significantly important in the embryogenesis of animals. The nematode 
develops into an elongated worm through contraction of the cytoskeleton and cell 
movement. The most important cells in this process are the hypodermal or epidermal cells. 
These cells form three layers consisting of the dorsal, lateral, and ventral epidermal cells 
that undergo various processes that eventually lead to the formation of the worm. 
Importantly, cell elongation occurs when the ventral and anterior epidermal cells extend 
their filpodia. This elongation process is essential for ventral closure during nematode 
deveopment (83). 
 
1.6.3   Lens Fiber Cell Elongation  
The Lens of the eye is a dynamic structure that is composed of two cell types - the anterior 
epithelial cells and the lens fiber cells. The lens fiber cells make up the bulk of the lens and 
is crucial to the its role in focuing light on to the retina (84).  Primary lens fiber cells arise 
when the posterior cells of the lens vesicle exit the cell cycle and down regulate the genes 
specific an epithelial cell fate and up-regulate the genes necessary for developing lens 
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transparency and its refractive index. Subsequently, these cells undergo a cell shape change 
from a cuboidal cell to an elongated cell. This is the first stage of cell elongation during 
lens formation (85).  
 
For the growth of the lens, proliferative cells in the germinative zone of the lens migrating 
down to the lens equator and differentiating into the secondary lens fiber cells. Secondary 
lens fiber cell production is a process that happens throughout the life. Similar to primary 
lens fiber cells, secondary lens fiber cell have an apical and basal polarity with the apical 
side attaching to the lens epithelium and the basal side attaching to the lens capsule. 
However, what is unique about the secondary lens fiber cells is that, unlike the primary 
fiber cells, they maintain their apical connection to the epithelial layer and elongate along 
the apical side of the epithelial layer. This elongation process stops when the apical sides 
of fiber cells come in contact with the apical side of another lens fiber cell from the other 
side of the lens. This same process also happens at the basal end of the lens as the secondary 
lens fiber cell remains attached to the lens capsule while it elongates and stops when it 
meets the basal end of another secondary lens fiber cell. The mechanism that governs lens 
fiber cell elongation is still under investigation (86) (16). 
 
The hypothesized mechanisms for lens fiber cell elongation currently consist of 
microtubules reorganization, increased cell volume, and actin cytoskeletal dynamics.  
Microtubules are an essential component of the cytoskeleton and are a part of the 
underlying membrane in shaping both primary and secondary lens fiber cells. It was 
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thought that microtubules of the lens are highly organized with the minus end towards the 
apical tip of lens fiber cells and the plus end facing the basal side of the lens. This 
observation was also supported by the presence of microtubule organizing centers, at the 
apical end of the lens fiber cells that are known to interact with the minus end of 
microtubules. In contrast, there are also studies that suggested microtubules are not 
necessary for lens fiber cell elongation such as the one done by Beebe et al in 1979 showing 
that inhibitions of microtubules do not effect cell elongation in chick lens explants. In 
addition, multiple studies have revealed other roles of microtubules in lens development 
that are independent of cell elongation (87).The complexity and true role of microtubules 
have yet to be fully elucidated.  
 
David Beebe’s group proposed another hypothesis that cell volume is the key factor in lens 
fiber cell elongation. Several experiment from this group revealed that lower amounts of 
potassium in the cell increased fluid influx into these cells, causing expansion of cell 
volume in cultured lens explants (88). Also studies using chicken lens cells demonstrated 
cell length correlated with the volume of the cell (89). Nevertheless, this model does not 
appear to be the dynamic processes that are involved in lens fiber cell elongation. The 
dynamics of the actin cytoskeleton are vital to cell adhesion and cell migration and have 
been hypothesized to also be a key factor in lens fiber cell elongation. Actin content and 
actin stress fiber are increased in elongated cells and disruption of actin impairs lens fiber 
cell elongation. Also, the transition of epithelial lens cells to differentiated fiber cells is 
closely associated with cytoskeleton reorganization and stabilization of cell-to-cell 
junctions. Consistent with this finding, disruption of actin stress fibers cause an increase in 
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differentiation markers and N-cadherin assembly (90). These evidence points to a strong 
association between lens fiber cell elongation and actin cytoskeleton dynamics.            
 
1.6.4 GTPases and Lens Development 
GTPases are a family of proteins that act as molecular switches that control biochemical 
pathways needed for multiple cellular processes. They control signal transduction by 
switching between two conformational states, active and inactive. In the inactive state, it is 
bound to a GDP.  These GTPase proteins become active when a Guanine Nucleotide 
Exchange Factor (GEF) will remove the GDP, allowing a GTP to bind. In the active state, 
GTPases interact with target proteins to induce downstream signaling until the GTPase 
Activating Protein (GAP) stimulates hydrolysis of GTP to GDP and the Guanine 
Nucleotide Dissociation Inhibitor (GDI) removes it from the membrane. There are several 
GTPases which can be divided into 5 major groups: Ras, Rho, Rab, Arf and Ran (91). 
GTPase have been studied for years for their roles in developmental processes.  
 
During lens development, members of the Ras and Rho family of GTPase contribute to cell 
proliferation, cell differentiation, and cell adhesion. Specifically, the small GTPase Ras has 
been extensively studied for its role in lens cell proliferation. The Ras gene was discovered 
as a retroviral gene in the 1970s and it can relay signaling after activation by growth factor 
receptors like the FGF receptor. The activation of Ras is controlled by at least three GEF: 
SOS, RAS-GRF and RAS-GRP. Multiple studies have established the role of SOS in 
receptor tyrosine kinase-mediated activation of RAS. SOS will bind the SH3 domain of the 
adaptor protein Grb2, which is recruited to a receptor kinase via its SH2 domain directly 
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or indirectly through a multi-protein complex. The association of SOS with the activated 
receptor brings it in close contact with Ras, turning it into GTP-bound activated Ras (92). 
Reneker et. al (98), have shown the lens of a transgenic mouse expressing a dominant 
negative form of Ras (dnRas) was dramatically decreased in size and growth compared to 
the wild type lens. To further confirm this observation, 5-bromo-2′-deoxuridine (BrdU) 
labeling was done on the both the dnRas lens and the wild type, which showed a two-fold 
decrease in BrdU labeled cells in the epithelial layer of the dnRas. There was also an 
increase in the number of apoptotic cells in the epithelial layer and lens fiber cells, 
indicating that Ras is important for cell survival in the lens. Consistent with this finding, 
Ras gain-of-function studies also show that cell proliferation was induced in the lens of 
transgenic mice. Ras can activate multiple downstream effectors and it has been shown that 
the activation of Erk in the lens is crucial for Ras-induced cell proliferation. Indeed, the 
lens of dnRas transgenic mice displayed a decrease in Erk activation and (U0126) cell 
proliferation is decreased in the lens explant treated with the Erk inhibitor. Overall Ras-
ERK signaling is crucial to cell proliferation, but more studies are needed to elucidate other 
roles of Ras in lens development (39,93). 
 
GTPase Rap1 is another member of the Ras family of proteins that has recently been 
investigated for its role in lens development. Rap1 is activated by several Rap1 GEF, 
among which C3G is the first one to be discovered. C3G binds to the SH3 domain of Crk 
and its phosphorylated form can activate Rap1. Other activators of Rap1 include CD-GE, 
Epac, PDZ-GEF, and DOCK-4. There are two distinct clear roles of Rap1 in cellular 
functions - cell proliferation and cell adhesion. It was found to attenuate Ras-Erk signaling 
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by possibly competing with c-Raf1 to inhibit proliferation, but in fibroblast cells it was 
found to increase cell proliferation maybe through binding of B-Raf independent of Ras. 
Further studies suggest that the differential roles of Rap1 in cell proliferation is highly cell 
type dependent. While the role of Rap1 in proliferation was controversial, its role in cell 
adhesion is clear.  Rap1 signaling is known to mediate inside-out activation of integrins 
through various stimuli. However, even when integrin is stimulated by an activating 
antibody or Mn2+, cell adhesion still required Rap1 activity. This revealed that Rap1 is 
required for the entire integrin-mediated cell adhesion process (94). In addition, other 
studies have uncovered a role for Rap1 in adherence junctions and tight junctions (95,96).   
 
Recently, Rap1 has been investigated for its role in lens development. The lens of the 
embryonic and neonatal Rap1 mutant mice initially displayed micropthalamia and 
opacification. Further analysis of various embryonic stages revealed severe defects in cell-
to-cell adhesion, cell-ECM adhesion, cell morphology and polarity.  In support the loss of 
adherence junctions, the levels of α-smooth muscle actin and various transcriptional 
inhibitors of E-cadherin were increased. Lastly, although differentiation was not affected, 
the Rap conditional knockout lens underwent apoptosis and cell cycle progression. These 
data are consistent with the role of Rap1 in adherence junctions and integrin mediated cell 
adhesion (97).  
 
The Rho family of GTPases is well known for their role in cell migration. One of the most 
extensively studied Rho GTPases is Rac. Rac was discovered as a Ras-related C3 
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botulinum toxin substrate 1 in 1989. Rac1, Rac2, and Rac3 are the three isoforms of Rac 
with Rac1 being the most extensively studied. Like all other GTPases, Rac is also activated 
by GEF, including Dock180. Activation of Rac1 leads to its interaction with downstream 
effectors such as PAK, IRSp53/WAVE, and IQGAP, all regulators of actin dynamics. Rac1 
has been implicated in reorganization of the cytoskeleton, lamellipodia formation, 
endocytosis and trafficking. Rac1 mediated actin polymerization is necessary for 
phagocytosis of microorganisms and a plethora of other cellular functions (98,99). 
 
Given the above role of Rac1 in actin dynamics, it is not surprising that Rac1 is responsible 
for lens shape and cell migration during lens development. Conditional deletion of Rac1 in 
the lens at embryonic day E14 resulted in abnormalities in cell shape, suture formation, 
lens fiber cell migration and orientation. The lens size was also decreased in the Racl 
mutant compared to the wild type. This lens size change was partly due to the apoptosis 
seen in both the lens epithelium and the lens fiber cells. There was also a defect in actin 
cytoskeleton organization and down-regulation of Rac1 downstream effector proteins such 
as WAVE-2 and Abi-2. Adherens junction was also decreased as indicated by a significant 
loss of E-cadherin (100). Other studies have found that a balance between RhoA and Rac1 
is essential for cell shape and lens placode invagination. RhoA is needed for apical 
constriction of lens epithelial cells during invagination and Rac1 is needed for lens cell 
elongation, both necessary for the invagination of the lens placode (15). In addition to 
integrin-controlled cell adhesion and cell migration pathways, growth factors can control 
reorganization of the cytoskeleton in lens cells (101). These finding has opened up a variety 
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of ideas of how crosstalk between the integrin and growth factor signaling pathways 
mediate lens development.   
 
1.7    Central Hypothesis   
The murine lens serves as a great model to study cellular processes such as cell 
proliferation, cell differentiation, cell adhesion, and cell migration because of its simplicity 
and accessibility to genetic manipulation in model organisms. With one single cross section 
of the mouse lens, defects in these cellular processes can be observed using 
immunohistochemistry and other visualization techniques.  Using the lens as model, our 
laboratory has previously studied the role of FGF signaling in lens development and 
revealed novel mechanisms of how FGF signaling mediates cell processes in the lens. For 
example, our laboratory established that the Frs2-Shp2 complex is the mediator of FGF 
signaling in lens development (48). In addition, there are a plethora of studies addressing 
the important  role of FGF signaling in lens cell differentiation and cell elongation (39). 
However, what mediates cell elongation during lens development is poorly understood. 
The adaptor proteins Crk and CrkL have been extensively study for their role in cell 
adhesion, cell migration, and cell shape (65). Therefore, we investigated the role of adaptor 
proteins Crk and CrkL in lens development and assess the molecular mechanism 
responsible for FGF mediated lens fiber cell elongation.  To explore this, we employed a 
lens specific Cre to conditionally knockout adaptor proteins Crk and CrkL in the lens at 
embryonic day 14 and assessed the phenotype using one of most widely used histological 
stains H&E, immunohistochemistry, immunocytochemistry, and TUNEL analysis. In 
addition, to further understand the cellular mechanism behind Crk and CrkL mediated lens 
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fiber cell elongation we conducted western blot analysis and utilized multiple transgenic 
mouse models.  
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CHAPTER TWO 
Material and Methods 
2.1 Mice and Genotyping  
Le-Cre (+) mice were crossed with homzygous Crkflox/flox/Crklflox/flox mice to generate Le-
Cre;Crkflox/flox/Crklfloxflox. Le-Cre mice were kindly provided by Dr. Ruth Ashery-Padan, 
Tel Aviv University, Tel Aviv, Israel and Dr. Richard Lang, Children's Hospital Research 
Foundation, Cincinnati, OH (102). Le-Cre;Crkflox/flox/Crklflox/flox was crossed with 
Transgenic (Tg) FGF3 mice to generate Le-Cre;Crkfloxflox/Crklflox/flox/Tg-FGF3 mice. 
Transgenic FGF3 mice were obtained from Dr. Micheal Robinson, Children's Hospital 
Research Foundation, Cincinnati OH (44). Le-Cre;Crkflxo/flox/Crklflox/flox were crossed with 
LSL(Lox-Stop-Lox)KrasG12D mice to generate Le-Cre;Crkflox/flox/Crklflox/flox/Kras mice. 
LSL-KrasG12D mice were obtained from the Mouse Models of Human Cancers Consortium 
(MMHCC) Repository at National Cancer Institute (103). Le-Cre (+) mice were crossed 
with Rac1flox/flox/Rac2flox/flox mice to generate Le-Cre;Rac1floxflox/Rac2flox/flox.  
Rac1flox/flox/Rac2flox/flox mice were obtained from Dr. Richard Lang, Children's Hospital 
Research Foundation, Cincinnati, OH (100). Le-Cre (+) mice were crossed with 
Rap1afloxflox/Rap1bflox/flox mice to generate Le-Cre;Rap1aflox/flox/Rap1bflox/flox. 
Rap1afloxflox/Rap1bflox/flox mice were obtained from Dr. Pongugoti V. Rao Department of 
Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, 
NC 27710, USA (97). The Constitutively active Rac1 was obtained from the Rajewsky 
laboratory. This lab has developed an inducible allele of Rac-1 (R26StopFLRACDA), 
which inserted a loxP flanked transcription stop cassette and a constitutively active G12V 
mutation in the endogenous Rac-1 locus (104).  Cre mediated recombination cleaved the 
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Stop cassette and activate the expression in a tissue-specific fashion. Therefore, I crossed 
R26StopFLRACDA with Le-Cre;Crk/Crklflox/flox to generate Le-Cre;Crk/Crklflox/flox ; 
R26StopFLRACDA. In all conditional knockout experiments, mice were maintained on a 
mixed genetic background and housed in a virus-free facility on a 12-h light-dark cycle 
and were fed a standard mouse food.  
 
For embryo generation female mice were checked daily for a semen plug, with morning of 
detection being considered Embryonic day 0. Pregnant females were sacrificed at the 
desired stage, and embryos dissected out in cold Phosphate Buffered Saline (PBS). 
Embryos were placed in 4% paraformaldehyde (PFA) for fixation. Yolk sacs and embryo 
tails were collected for embryo genotyping. Genotyping was done using polymerase chain 
reaction (PCR) with various genes specific primers (see table 2.1 for primer sequence). 
Mouse maintenance and experimentation was performed according to protocols approved 
by the Indiana University School of Medicine and Columbia University Institutional 
Animal Care and Use Committee.   
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Table 2.1 Primer Sequence 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.2 Cell Culture  
 Mouse Embryonic Fibroblast (MEF) Cells—Primary MEF cells were isolated from 
embryos at the E13.5 to E14.5 stage. Briefly, the uterine horns were dissected from 
pregnant females and rinsed in 70% (v/v) ethanol before transfer into sterilized PBS. After 
the heads and the internal organs were cut away, the trunks were washed with fresh PBS 
to remove blood cells, finely minced into small pieces in a minimal amount of PBS, and 
digested in 1–2 ml of 0.25% trypsin-EDTA for 10 min at 37 °C under gentle agitation. The 
supernatant was combined with 2 volumes of fresh Dulbecco’s modified Eagle’s medium 
Primer 
Name 
Primer Sequence 
Cre Forward: AACATGCTTCATCGTCGGTC  
Reverse: GAGTTGATAGCTGGCTGGTG 
Crk Forward KO: GGGTGACCTGAGAACTGACC 
Forward Flox: TCACTTATCCTGGGAATTGGA 
Reverse WT: CAGCTCGGACTGCAGAATG 
CrkL Forward (CrkL-bPacG1): AGGGTGAGGCGACTTCATAA 
Forward (CrkL-bAatG1): TCACTTATCCTGGGAATTGGA 
Forward (CrkL-NeoTk-1): GGAGAGGCTTTTTGCTTCCT 
Reverse (CrkL-aPacG2): CCACCCCACCTTCATTATTC 
K-Ras Forward: TTGCAGAACTGCTCTGATGG 
Reverse: GCTCCAACCACCACAAGTTT 
          Rac1 Forward: TCCAATCTGTGCTGCCCATC 
Reverse: GATGCTTCTAGGGGTGAGCC 
Rac2 Rac2-common: GACGCATGCTCCACCCCCT 
Rac2-PGKneoF2: TGCCAAGTTCTAATTCCATCAGAAGC 
Rac2-ex1: CACACACTTGATGGCCTGCAT 
Rap1a Forward: CCAAGGCTCTCAGTTGATTTCTA 
Reverse: TATCTGCACATAATCTGCATGCC 
Rap1b Forward: CCCTCTCATGCTATTCCTAATGT 
Reverse: GCCACCTCAGTAGAAAAGACC 
391 (Tg-FGF3) Forward: CCCAGAGGCTCCTGTCTGACTCACT 
Reverse: GTACTTGGTAGCGCAGTAGAGC 
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(DMEM) and centrifuged at a low speed (400 g). The cell pellet was re-suspended in 
DMEM containing 10% FBS (Fetal Bovine Serum) and antibiotics (penicillin 
G/streptomycin 1:100) and cultured in a humidified 5% CO2 incubator at 37 °C. MEFs 
from the second passage were infected with Ad5CMVCre   (Gene Transfer Vector Core, 
University of Iowa, IA) overnight at multiplicity of infection 100 plaque-forming units/cell 
and cultured for 2 more days after replacing with fresh culture medium.  
  
2.3 Histology and Immunohistochemistry 
After overnight fixation in 4% paraformaldehyde (PFA), the embryos were dehydrated 
progressively through 30, 50, 70, 90 and 100% ethanol, cleared in xylene and embedded 
in paraffin. The paraffin sample blocks were oriented on a Leica 2125 microtome and 
sectioned at 10 μm. For cryosections, the embryos were incubated in 30% sucrose 
overnight and cryoembedded using OCT (Optimal Cutting Temperature) compound. 
Section were cut at 10 µM using a Leica CM 1850 microtome.  Paraffin sections were 
stained with Hematoxylin and Eosin (H&E), and mounted with coverslips, before digital 
pictures of the sections were taken on a Leica DM3000 compound microscope at 10x and 
20x magnification. Lens sizes were measured by the maximum area of the lens using the 
ImageJ program (National Institute of Health, Bethesda, MD), and the statistical 
significance was calculated by a two-tailed t-test. Regular immunostaining was performed 
on the cryosections or paraffin embedded sections (10 µm). Antigen retrieval was 
performed by microwave heating for 10 minutes at sub-boiling condition in citrate buffer 
(10 mM sodium citrate, pH 6.0). Non-specific interaction was blocked by 5% goat serum 
in PBS at room temperature for 1 hour. Sections were incubated with primary antibody at 
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4°C overnight in a humid chamber and placed in secondary antibody (1:250 Alexa Flour 
488; 1:500 Alexa Fluor 555) for one hour the next day. Sections were stained with 4,6-
diamidino-2-phenylindole (DAPI) (1:5000) for nuclear staining, pictures were taken with 
a compound microscope. For phospho-Erk staining, the endogenous peroxidase activity on 
cryosections was quenched with 3% H2O2 in 10% methanol/PBS solution for 10 minutes 
before blocking for non-specific interactions. Phospho-Erk signaling was amplified using 
a Tyramide Signal Amplification (TSA 1:50) kit (TSA™ Plus System, PerkinElmer Life 
Sciences, Waltham, MA). Cell proliferation was quantified by counting the number of Ki67 
positive cells versus DAPI-positive cells, and analyzed by two-tailed student t-test. 
Staining of F-Actin was performed by incubating sections with the Alexa Flour 488 
phalloidin (1:100) for one hour. The maximum length of lens fiber cells was measured 
using the ImageJ program (National Institute of Health, Bethesda, MD), and the statistical 
significance was calculated by two tailed t test.   Antibodies used were:  anti-Crkl (Santa 
Cruz sc-319) anti-phospho-ERK1/2 (cell signaling #4370), anti-P57 (ab75974) (from 
Abcam, Cambridge, MA), anti-E-cadherin (U3254, Sigma, St Louis, MO), anti-jagged1 
(sc-6011 santa cruz) anti-Ki67 (#550609, from BD Pharmingen San Diego, CA), anti-
Prox1 (PRB-238C) and anti-Pax6 (PRB-278P) (both from Covance, Berkeley, CA) 
Laminin (L9393 Sigma St. Louis MO), Active β-Integrin (BD Pharmingen San Diego, 
CA), Integrin AIIB2 (Developmental Studies Hybridoma Bank, Iowa City, IA), beta-
dystrogylcan (Developmental Studies Hybridoma Bank, Iowa City, IA), Anti-Paxillin (BD 
Transduction Laboratories), Collagen type IX D1-9 ( Developmental Studies Hybridoma 
Bank, Iowa City, IA), anti-Arpc2 (ab11798 Abcam, Cambridge, MA) , anti-phospo-
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Paxillin (#2541 cell signaling). The antibody against α-crystallin was kindly provided by 
Sam Zigler (National Eye Institute, Bethesda, MD) (see table 2.2 for antibody dilution).  
 
2.4 Immunocytochemistry 
For immunostaining, MEF cells were cultured on round glass coverslip (corning #1 0211 
glass #CLS-1763 Chemglass Life Science) and washed with PBS and fixed with 
4% paraformaldehyde and incubated in PBS supplemented 10% NGS and 0.2 % triton X-
100 for blocking nonspecific antibody binding. Cells were incubated with primary 
antibodies (Active β-Integrin (BD Pharmingen San Diego, CA) and anti-phospo-Paxillin 
(#2541 cell signaling) for 1 h at room temperature, washed in PBS and incubated with 
Alexa fluor 488 dye-conjugated secondary antibodies (1:250) or phalloidin (1:100) 
(Invitrogen) for 40 min at room temperature. After extensive wash, coverslips were 
mounted with Vectashield mounting medium containing DAPI (1:1000) (Vector 
Laboratories, Burlingame, CA, USA) (see table 2.2 for antibody dilution). 
 
2.5   Cell Protein Extract Isolation and Western Blots 
4.24–6.36×105 MEF cells infected with Ad5CMVCre were seeded in 60 mm dishes and 
serum starved (0.5% FBS in DMEM) for 36–48 hours before being stimulated by 50 ng/ml 
FGF2 (R&D Systems, Minneapolis, MN) for 5 minutes at 37°C. After washing twice in 
cold PBS, MEF cells were lysed in 160 µl RIPA buffer (50 mM Tris-HCl, pH 8.0, 150 mM 
NaCl, 1% NP40, 0.5% sodium deoxycholate, 0.1% SDS, 1 µg/ml aprotinin, 1 µg/ml 
pepstatin, 10 mM sodium pyrophosphate, 1 mM PMSF, 0.2 mM Na3VO4, 50 mM NaF) 
and a Bradford protein assay was used to determine the protein concentration from cell 
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lysates. 6x Laemmli buffer was added to 30-60 ug of protein lysate and then boiled at 100° 
C for 5 minutes. Equal amount of protein was loaded into the wells of a 10-12% SDS-page 
gel, along with a molecular weight marker. Gels ran for 1-2 hours at 100 volts in a 
electrophoresis cell containing 1x running buffer (25mM Tris base, 190 mM glycine, 0.1% 
SDS). The gel was then transferred to a PVDF membrane for protein analysis using wet 
elctroblotting (Tank Transfer) containing transfer buffer (25 mM Tris base, 190 mM 
glycine, 20% methanol). Proteins were visualized by infrared-based western blot analysis 
using an Odyssey SA scanner (LICOR Biosciences, Lincoln, NE). The signal intensity was 
quantified using the Odyssey software. The antibodies used were mouse anti-phospho-
ERK1/2 (sc-7383, santa cruz), anti-phospho-Crk (tyr221) (cell signaling #3491) (see table 
2.2 for antibody dilution).   
 
2.6   TUNEL Analysis 
TUNEL staining was performed with an in situ cell-death detection kit (Roche, 
Indianapolis, IN, USA). Briefly, cryosections were processed for antigen retrieval as 
described above, incubated with blocking buffer (0.1 M Tris-HCl, pH 7.5, 3% BSA, 20% 
serum) for 30 minutes at room temperature and then with TUNEL reaction mixture for 2 
hours at 37°C. After rinsing with PBS, the sections were blocked again with 0.05% 
blocking reagent (supplied in the TSA Indirect Tyramide Signal Amplification Kit, Perkin 
Elmer Life Science, Boston, MA, USA) for 30 minutes and then incubated with TUNEL-
POD for 30 minutes at 37°C. Finally, the signal was developed with DAB substrate and 
detected under a Leica DM500 microscope at 10x and 20x magnification. 
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                                 Table 2.2 Primary Antibody Dilutions 
Primary Antibody 
Name 
Primary Antibody Dilution 
anti-Active β-
Integrin 
1:100  
anti-Arpc2  1:100  
Collagen type IX   
D1-9 
1:100  
anti-Crkl 1:200  
Crystallin (α) 1:1000  
anti-Dystrogylcan (β) 1:100 
anti-E-cadherin 1:200 
Anti-ERK 1/2  1:1000 Western Blot 
anti-Integrin AIIB2 1:100 
anti-jagged1 1:100 
anti-Ki67 1:200 
anti-Laminin (L9393) 1:1000 
anti-Paxillin 1:100 
anti-Pax6 1:250 
anti-phospho-Crk 
(tyr221) 
1:2000 Western Blot 
anti-phospho-
ERK1/2 
1:200 IHC  1:2000 Western 
Blot  
anti-phospho-
Paxillin 
1:50 
anti-Prox1 1:500 
anti-P57 1:100 
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CHAPTER THREE 
Results 
3.1 The Role of Adaptor Crk and CrkL in Lens Development 
3.1.1 Conditional deletion of Crk and CrkL in the lens 
To determine the role of adaptor proteins Crk and CrkL in lens development. Mice that 
express the lens specific Cre recombinase controlled by the Pax6 promoter were mated 
with mice that contained the Crk and CrkL flox alleles. Their progeny will contain 
conditional deletion of Crk and CrkL in the lens in the presences of Cre recombinase 
(Figure 7.). To verify deletion of Crk and CrkL using the Cre/loxP system, immunostaining 
with a CrkL antibody was performed on the wild type and Le-Cre;Crkflox/flox /CrkLfloxflox 
lens. CrkL was deleted as early as E10.5 and was also lost in both the E12.5 and E14.5 lens 
(Figure 8.). To confirm whether or not Crk and CrkL can compensate for each other during 
lens development, I deleted each individually in the lens using the Cre/loxP system. Neither 
Crk nor CrkL had a severe phenotype in the lens, although CrkL appeared to have a slightly 
more significant phenotype than Crk (Figure 9.). These data suggest that during lens 
development Crk and CrkL can compensate for each. Therefore, all studies carried out in 
this thesis had both Crk and CrkL deleted in the lens. 
 
3.1.2 Conditional deletion of Crk and CrkL in the lens cause defects 
To begin to understand the role of adaptor proteins Crk and CrkL in lens development, we 
deleted Crk and CrkL in the lens at embryonic day 14. H&E and immunohistochemistry 
staining revealed a severe phenotype in the Le-Cre;Crkflox/flox /CrkLfloxflox  lens compared to 
wild type. The Le-Cre;Crkflox/flox /CrkLfloxflox  lens displayed a reduction in lens size,  
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Crk/Crkl
flox/flox
 
Figure 7. Le-cre/loxP recombination system for Crk and Crkl conditional 
knockout mice.  A) Mouse with Cre recombinase enzyme expressed under the 
control of a pax6 promoter. B) Mouse with a targeted Crk and CrkL floxed allele. 
C) Mouse with lens specific deletion of floxed alleles in which cre recombinases is 
expressed in the lens.   
 
A. B. 
C. 
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Figure 8. Conditional deletion of CrkL in the developing lens. (A-F) Cross sections of 
the embryonic mouse lens at three different stages. CrkL immunostaining was markedly 
reduced at embryonic day 10.5, 12.5, and 14.5 in the Le-Cre;Crkflox/flox /CrkLfloxflox  lens (D-
F arrows) .  
  
A. B. C. 
 D. E. F. 
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  Figure 9. Crk and CrkL can compensate for each other during lens development. 
(A-D) H&E staining at embryonic day 14.5 of the mouse lens. B) The Le-Cre;Crkflox/+ 
/CrkLflox/+ lens exhibits a very mild phenotype. (C-D) Le-Cre;Crkflox/flox and Le-
Cre;CrkLfloxflox lens display a mild phenotype with the Le-Cre;CrkLfloxflox being slightly 
more severe. 
  
A. B. C. D. 
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Figure 10. Phenotype of Le-Cre;Crkflox/flox /CrkLfloxflox lens. (A-A’) The Le-Cre;Crkflox/flox 
/CrkLfloxflox  lens size is reduced and the phosphorylation of Crk is also lost. (B-B’) The 
anterior epithelium of the lens is rotated in Le-Cre;Crkflox/flox /CrkLfloxflox lens (indicated by 
arrow). (C-C’) The Le-Cre;Crkflox/flox /CrkLfloxflox lens also displayed  disorganization of the 
lens fiber cells as well as a decrease in lens fiber cell length (indicated by arrow). D) Lens 
size measurements of the Le-Cre;Crkflox/flox /CrkLfloxflox compared to wild type. A student t-
test was preformed on three different lens for each phenotype. 
 
A. C. 
A’ 
B. 
B’ 
A 
C’ 
D. 
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rotation of the lens epithelial layer, and disorganization of the lens fiber cells. Lastly, one 
of the most striking phenotypes was a decrease in lens fiber cell length. The wild type and 
Le-Cre;Crkflox/flox/CrkLfloxflox lens was stained with an Alexa flour 488 conjugated 
phalloidin. Phalloidin is a member of phallotoxins derived from poisonous mushrooms and 
is used to observe actin and cell shape because it has the ability to bind and stabilize actin 
filaments. In this study it was specifically used it as a guide to measure lens fiber cell 
length. The length of lens fiber cells appeared to be decreased in the Le-Cre; Crkflox/flox 
/CrkLfloxflox lens. The wild type and Le-Cre;Crkflox/flox /CrkLfloxflox lens size was also 
quantified to confirm reduction in lens size (Figure 10. D).  
 
To further analyze the role of Crk and CrkL in lens development, we begin by staining the 
Le-Cre;Crkflox/flox /CrkLfloxflox lens with differentiation markers. We stained the Le-
Cre;Crkflox/flox /CrkLfloxflox lens with Prox1, Pax6 and multiple forms of Crystallin. Prox1 is 
a homeodomain protein that is essential for lens fiber cell differentiation and elongation 
(105). Pax6 is a transcription factor that is essential for ocular development and deletion of 
Pax6 using the lens specific Cre recombinase resulted in the absence of the lens (102).  
Similar to Prox1, Crystallin is present in lens fiber cells, with α-Crystallin making up about 
40% of the lens protein with another 50% being β and γ crystallin (106). Staining with 
these specific markers revealed that the Le-Cre;Crkflox/flox /CrkLfloxflox  lens displayed no 
changes in Prox1, Pax6, or the three forms of  Crystallin , indicating that Crk and CrkL are 
not essential for lens fiber cell differentiation (Figure 11. A-G’). 
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Figure 11. Conditional deletion of Crk and CrkL in the lens does not have effect on 
lens determination and differentiation proteins. (A-D’) Prox-1 and Pax-6 was 
performed on the control and Le-Cre;Crkflox/flox /CrkLfloxflox lens. There are no significant 
changes in staining intensity with the lens determination marker Pax-6 and the lens 
differentiation marker Prox-1. (E-G’) Immunohistochemistry training with three different 
forms of Crystallin (α, β, γ). All three forms of Crystallin did not display any changes in 
staining intensity at embryonic day 14. 
E F 
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Figure 12. Conditional knockout of Crk and CrkL in the lens cause a decrease in lens 
cell proliferation and an increase in apoptosis during lens development. (A-A’) Ki67 
was decreased in the Le-Cre;Crkflox/flox /CrkLfloxflox  lens compared to the wild type at 
embryonic day 14. (B-B’) TUNEL staining was present in the Le-Cre;Crkflox/flox /CrkLfloxflox  
lens at embryonic day 14. (C) Relative ratio percentage of proliferation and apoptosis in 
the wild type and Le-Cre;Crkflox/flox /CrkLfloxflox  lens. A student t-test was preformed on 3 
different lens for each phenotype. 
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In addition to differentiation lens cell proliferation is essential for embryonic lens 
development. Therefore, we stained the lens with Ki67 which is considered a proliferation 
marker because its expression is detected in the nucleus during interphase and is present in 
all active phases of the cell cycle except the resting cell G (0) (107). When stained with 
Ki67, the Le-Cre;Crkflox/flox /CrkLfloxflox lens revealed a decrease in lens cell proliferation 
(Figure 12. A-A’). The number of proliferating cells was counted and analyzed using the 
student’s t-test.  
 
To investigate whether the small lens seen in the Le-Cre;Crkflox/flox /CrkLfloxflox  lens was due 
to lens epithelial cells undergoing apoptosis, TUNEL staining was performed on the lens 
at embryonic day 14. Comparing the wild type and Le-Cre;Crkflox/flox /CrkLfloxflox  lens, there 
was a significant increase in TUNEL staining in the Le-Cre;Crkflox/flox /CrkLfloxflox lens 
(Figure 12. B-B’). Therefore, the small lens observed is at least partly due to lens epithelial 
cell apoptosis. To confirm are analysis we performed a student t-test to observed the 
relative ratio of cell proliferation and apoptosis (Figure 12. C).  
 
3.1.3 Deletion of Crk and CrkL causes extracellular matrix and cell adhesion defects 
of the lens.  
Adaptor proteins Crk and CrkL play an important role in the formation of the extracellular 
matrix. Therefore, it is imperative to observe whether or not deletion of Crk and CrkL in 
the lens has any extracellular matrix defects. To explore this possibility, I conducted 
immunohistochemistry staining with cell surface receptors and basement membrane 
markers. There are two cell surface receptor that are important for connecting the 
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extracellular matrix to the cytoskeleton, Integrin and Dystroglycan. Integrin is a 
bidirectional cell surface receptor that is important for basement membrane assembly, cell 
shape, cell migration, and cell survival (108).  Similar to Integrin, Dystroglycan was also 
thought to be important for basement membrane assembly. Dystroglycan is a 
transmembrane protein that is a member of the Dystrophin Glycoprotein Complex and is 
known as the link between the extracellular matrix and the cytoskeleton (109).  At 
embryonic day 14, both B1 integrin and Dystrogylcan was reduced in the Crk and CrkL 
conditional knockout lens (Figure 13. A-D). The connection of the extracellular matrix to 
the cytoskeleton is also maintained by the binding of integrin to the components of the 
basement membrane (110). Immunostaining with components of the basement membrane 
like Collagen and Laminin was also decreased in the Crk and CrkL conditional knockout 
lens (Figure 13. E-H). From this data, it is concluded that during lens development Crk and 
CrkL play a role in maintaining the extracellular matrix.  
 
Both Crk and CrkL are also essential for the motility and adhesion of the cell. One of the 
most important events in cell adhesion occurs when Integrin binds to its ligand such as 
Laminin and Collagen. Binding of Integrin to its ligands leads to activations of proteins 
like FAK and Src (111). FAK or Src will phosphorylate Paxillin and recruit Crk (112). Crk 
actives Rac1 which leads to the phosphorylation of the effector p21-activated kinase 
(PAK). PAK then binds to the actin nucleator complex Arp2/3. The Arp2/3 is responsible 
for actin nucleation and lamellipodia formation (15). Lamellipodia are membrane 
protrusion that facilitates the clustering of and binding of transmembrane cell surface 
receptors to the substratum components or formation of cell adhesions. To investigate if  
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Figure 13. Deletion of Crk and CrkL causes extracellular matrix defects of the lens. 
(A-D) The Le-Cre;Crkflox/flox /CrkLfloxflox  lens exhibits a significant loss of the cell surface 
receptors Integrin and Dystrogylcan compared to wild type. (E-H) The Le-Cre;Crkflox/flox 
/CrkLfloxflox lens display a significant loss of basement membrane markers compared to wild 
type. 
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Figure 14. Cell adhesion is disrupted in the Crk and CrkL conditional knockout lens. 
(A-D) Mouse Embryonic Fibroblast (MEF) cells lose focal adhesion and cell spreading 
ability. (A’-B’)  Arpc2 is decreased in the lens epithelial layer (indicated by errors) of the 
Le-Cre;Crkflox/flox /CrkLfloxflox lens at embryonic day 13. (A’’-B’’) In the Le-Cre;Crkflox/flox 
/CrkLfloxflox mutant lens, there was a reduction in Paxillin staining at embryonic day 14.                                 
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this process is interrupted by the deletion of Crk and CrkL during lens development, I 
conducted immunofluorescence staining with activated Integrin, phospho-Paxillin, and 
Arpc2 (member of the Arp2/3 complex). Deletion of Crk and CrkL in Mouse Embryonic 
Fibroblast (MEF) cells revealed a loss of activate Integrin, phospo-Paxillin, and cell 
spreading (Figure 14 A-D). In the Crk and CrkL conditional knockout lens there was also 
a decrease in Arpc2 and Paxillin (Figure 14.). This data taken together reveal that Crk and 
CrkL are important for cell adhesion and cell spreading.  
 
3.1.4 Deletion of Crk and CrkL cause a decrease in the downstream effector phospho-
ERK of FGF signaling pathway.   
It is clear that both Crk and CrkL can interact with FGF receptors to induce downstream 
signaling (68) (69). However, the downstream effectors that are activated by the interaction 
between the FGF receptor and Crk/CrkL is poorly understood. To begin investigating the 
role of Crk and CrkL in FGF signaling during lens development, I accessed whether or not 
Crk and CrkL can cause activation of phospho-ERK. ERK (Extracellular signaling 
regulated kinase) or MAPK (Mitogen-activated protein kinase) is a member of a three 
protein cascade that eventually leads to its activation (113). ERK is activated by its 
phosphorylation and is a major component of pathways controlling cell proliferation, cell 
differentiation, and embryonic development (114). One of the known pathways that ERK 
play a role in is the FGF signaling pathway. FGF signaling and the activation of ERK are 
both essential for lens development. Therefore, we hypothesize that Crk and CrkL mediates 
activation ERK during lens development. Stimulation of phosphorylated ERK by FGF2 in 
Crk and CrkL deleted MEF cells appeared to be decreased compared to wild type MEF 
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Figure 15. Deletion of Crk and CrkL cause a decrease in the downstream effector phospho-
ERK of FGF signaling pathway. (A) Mouse Embryonic fibroblast (MEF) cells were obtained 
from Crk/Crkl flox embryos at embryonic day 14.  Using an adenovirus cre, Crk/Crkl was deleted 
by the cre-lox method, a western blot was performed to assess the quantity of phospho-ERK 
following deletion of Crk/Crkl. In the presence of FGF2 there was a sharp reduction of 
phospho-ERK stimulation in the Cre;Crk/Crkl MEF cells. (B,C) The Le-Cre;Crkflox/flox 
/CrkLfloxflox   lens displayed a drastic decrease in phospho-ERK staining compared to the wild type. 
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cells (Figure 15. A). In addition, conditional deletion of Crk and CrkL in the lens at E14 
resulted in a reduction in phosphorylation of ERK (Figure 15 B-C). These data explain that 
Crk and CrkL are mediating FGF signaling via ERK activation during lens development.  
 
3.1.5 The Tg-Fgf3 gain of function phenotype is lost in the presences of the Crk/CrkL 
conditional KO mutation.  
To further confirm that Crk and CrkL is contributing to FGF signaling during lens 
development, we used a transgenic mouse that contains a αA-crystallin promoter to target 
expression of FGF3 in the developing lens. Expression of FGF3 in the lens at E14 results 
in a gain of function phenotype with premature differentiation and ocular proptosis (44). 
Therefore, transgenic FGF3 mice were mated with Crk and CrkL conditional knockout 
mice to assess if there was an epistatic relationship between Crk/CrkL and the FGF 
receptor. Deletion of Crk and CrkL in the presences of transgenic FGF3 led to a phenotype 
very similar to Crk and CrkL deletion alone (Figure 16. A-H). In addition, the deletion of 
Crk and CrkL in the presences of the transgenic FGF3 also displayed a decrease in lens 
fiber cell length similar to the Crk and CrkL conditional knockout (Figure 16. I).  Therefore, 
it was concluded that Crk and CrkL are epistatic to the FGF receptor. 
 
3.1.6 Constitutive Kras signaling can compensate for the loss of Crk and CrkL in lens 
development.  
Downstream FGF signaling can be carried out through activation of the GTPase Ras. 
Therefore, it is hypothesized that Ras signaling could be the target of Crk and CrkL during 
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lens development. In a genetic rescue experiment, the Le-Cre; Crkflox/flox, Crkl 
flox/flox mutants were crossed with the LSL-KrasG12D allele, which can be induced to express 
a constitutively active KrasG12D mutant by Cre-mediated recombination. TUNEL staining 
was performed on the Le-Cre; Crk flox/flox; Crkl flox/flox LSL-KrasG12D and consistent with our 
previous report (115), abnormal cell apoptosis, as indicated by TUNEL staining, was not 
rescued by activated Kras signaling (Figure 17 A-A’’). Also double staining with 
proliferation and differentiation markers Ki67, E-cadherin, p57 and jagged-1, respectively.  
Ki67 has been previously discussed and E-cadherin is a cell-to-cell adhesion molecule 
important for the behavior of epithelial cells and the function of multiple tissues such as 
the lens (116). p57 is a cell cycle inhibitor that is presents in cells that have exited the cell 
cycle. E-cadherin is only found in the proliferating epithelial layer of the lens. Jagged-1 is 
a ligand that binds to the Notch receptor and is essential for lens fiber cell differentiation 
(117). Double staining with the various markers revealed there was no significant 
difference in staining intensity (Figure 17. B-C’’). However, Results show that despite the 
loss of Crk and CrkL in the Le-Cre; Crk flox/flox;Crkl flox/flox LSL-KrasG12D mutant, Lens size 
was rescued and it was accompanied by induced ERK phosphorylation (Figure 17. A-D, 
A’-D’, E).    
 
To begin understanding what cellular processes are mediated by Crk and CrkL activated 
Ras, immunohistochemistry staining was done with β1 Integrin, Dystrogylcan, Laminin, 
and Paxillin. Le-Cre; Crk flox/flox ;Crkl flox/flox LSL-KrasG12D mutant still displayed a loss of 
the cell surface receptors, cell membrane, and cell adhesion markers similar to Le-Cre; Crk 
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flox/flox ;Crkl flox/flox alone (Figure 18. A-L). The ability for Kras to rescue some but not all of 
the Crk and CrkL mutant phenotypes reveals that Crk and Crkl mediates other pathways  
 
 
 
 Figure 16. The Tg-Fgf3 gain of function phenotype is lost in the presences of the 
Crk/Crkl conditional KO mutation. (A,B,C,D) In the presences of the Tg-Fgf3 the 
Crk/CrkL KO lens has a similar phenotype to the Crk/CrkL conditional KO indicated by 
the small lens size. (E,F,G,H) A less severe strain of the Tg-FGF3 391, was also observed 
in the presences of the Crk/CrkL knockout lens and also showed a similar phenotype to the 
Crk/Crkl conditional KO. I) Relative lens fiber cell length in the wild type, Crk/Crkl 
conditional KO, the Crk/Crkl conditional KO;Tg-Fgf3, and Tg-Fgf3 lens revealed a  drastic 
decrease in lens fiber length in the Crk/Crkl conditional KO and the Crk/Crkl conditional 
KO;Tg-Fgf3 lens. A student t-test was preformed on three different lens for each 
phenotype. 
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Figure 17. Constitutive Kras signaling can compensate for the loss of Crk and 
CrkL in lens development. (A-A’’) TUNEL staining was present in the Le-Cre;Crkflox/flox 
;CrkLfloxflox lens at E14 remained significantly elevated in Le-Cre;Crkflox/flox 
;CrkLfloxflox;LSL-KrasG12D lens. (B-B’’ and C-C’’) There was no significant difference in 
staining intensity when the lens was stained with proliferation and differentiation markers. 
(D-D’’) Despite the loss of Crk and CrkL, ERK phosphorylation recovered in Le-
Cre; Crkflox/flox; CrkLflox/flox; LSL-KrasG12D mutant lens. (E-E’’) The lens fiber cell length 
observed in the Le-Cre;Crkflox/flox ;CrkLfloxflox  lens appeared to be rescued in the Le-
Cre; Crkflox/flox; CrkLflox/flox; LSL-KrasG12D mutant lens. F) Fiber cell length was measured 
and quantified. A student t-test was preformed on three different lens for each phenotype. 
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Figure 18. Activated Ras did not rescue the ECM and cell adhesion defect in the Crk 
and CrkL mutant lens. (A-F) The Le-Cre;Crkflox/flox ;CrkLfloxflox ; LSL-KrasG12D   lens 
exhibits a significant loss in the staining of the cell surface receptors Integrin and 
Dystrogylcan compared to wild type. (G-I) The Le-Cre;Crkflox/flox ;CrkLfloxflox ; LSL-
KrasG12D lens display a significant loss of the basement membrane marker laminin  
compared to wild type. (J-L) In Le-Cre;Crkflox/flox ;CrkLfloxflox ; LSL-KrasG12D mutant lens, 
there was a reduction in Paxillin staining at  E14.                
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during lens development in addition to Ras signaling pathway. The Ras-MAPK pathway 
is known to promote cell survival, therefore the rescue of the Crk and CrkL mutant lens 
could be due to suppression of apoptosis by Ras. This scenario is plausible because Kras 
similarly cannot rescue some of the Crk and CrkL phenotype such as the lens epithelial 
layer rotation and the ECM defects.  
 
3.2 Crk and CrkL are required for lens fiber cell elongation 
3.2.1 Crk and CrkL and required for lens fiber cell elongation but not differentiation                                      
Cell differentiation and cell elongation are two dynamic processes that appear to proceed 
sequentially. During lens development, secondary lens fiber cells will differentiate first and 
then elongate along the epithelial layer and the lens capsule. Although cell elongation 
happens after cell differentiation, are they controlled by the same pathway? To answers 
this question, we conducted immunohistochemistry staining using three sets of markers 
that specifically stain the lens epithelium and the lens fiber cells on the Le-Cre; Crkflox/flox; 
CrkLfloxflox, Le-Cre;Crkflox/flox ;CrkLfloxflox ;Tg-Fgf3, and the Tg-Fgf3 mice. What is unique 
about the Tg-Fgf3 is that this transgene causes premature differentiation of lens epithelial 
cells and an increased in lens size compared to the wild type. Interestingly, Crk and CrkL 
can inhibit the lens size but not the premature differentiation indicated by the precocious 
appearance of differentiation markers p57, Jagged-1, and C-Maf in the epithelial layer of 
the lens in both the Tg-Fgf3 lens and the Le-Cre;Crkflox/flox ;CrkLfloxflox ;Tg-Fgf3 lens (Figure 
21. A-K). These data indicate that Crk and CrkL is not necessary for lens fiber cell 
differentiation but they are required for fiber cell elongation.  
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Figure 19. Crk/CrkL deletion prevents FGF-induced cell elongation without affecting 
differentiation. (A-K) The deletion of Crk and CrkL did not prevent the premature 
differentiation phenotype of the Tg-Fgf3 lens indicated by the presences of three 
differentiation markers (p57, Jagged-1, and C-Maf) in the presumptive epithelial layer of 
the Tg-Fgf3 and Le-Cre;Crkflox/flox ;CrkLfloxflox ;Tg-Fgf3 lens (see arrows).      
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Figure 20.  Crk/CrkL, Shp2, and Frs2 interact with each other during lens fiber cell 
elongation.  (A-C) Shp2 was successfully deleted in the Le-Cre;Crkflox/flox ;CrkLfloxflox ; 
Shp2 floxflox. D) phospho-Crk was drastically reduced in Shp2 deleted MEF cells. (E-G) 
Phospho-Erk staining was loss in the Le-Cre;Crkflox/flox ;CrkLfloxflox ; Shp2 floxflox compared  
to the  Le-Cre;Crkflox/flox ;CrkLfloxflox and the wild type.   
 
 
 
 
 
 
 
A. 
 
B. C. 
A’ B’ C’ 
D. 
E. 
  
  
71 
3.2.2 Crk/CrkL and Shp2 have a synergistic relationship during lens fiber cell 
elongation 
 To address whether Crk is acting alone or synergistically with other proteins to mediate 
FGF signaling in regulating lens fiber cell elongation, I deleted Crk, CrkL, and Shp2 
together in the lens at embryonic day 12 and 14. Complete deletion of Shp2 in the lens was 
confirmed by immunohistochemistry staining with Shp2 (Figure 22. A-C). Shp2 is a 
protein tyrosine phosphatase intimately involved in multiple cellular activities including 
cytoskeletal maintenance and cell differentiation (118). Shp2 is also a key factor in 
regulating the FGF signaling pathway during lens development (115). It was previously 
shown that conditional deletion of Crk and CrkL in the lens resulted in a decrease in 
phospho-ERK signaling at embryonic day 14 (Figure 15. C). This drastic loss of phospho-
ERK was also present at embryonic day 12 (Figure 22. B’). Surprisingly, deletion of Crk, 
CrkL, and Shp2 together led to a complete loss of phospho-ERK staining (Figure 22. C’). 
Supporting this data, deletion of Shp2 in MEF cells prevents FGF signaling from 
stimulating phospho-Crk (Figure 22. D). This indicates that Shp2 controls the activity of 
Crk downstream during FGF signaling to mediate lens fiber cell elongation.  
 
In addition to Shp2 being one of the main mediators of FGF signaling, Frs2 is another 
protein that is known to be essential for FGF signaling. Frs2 acts as a scaffolding or docking 
protein that is activated via its phosphorylation by receptor tyrosine kinases such as the 
FGF receptor. Once Frs2 get phosphorylated  it contains binding sites for proteins like Shp2 
that aid in the induction of essential cell signaling pathways (119). Therefore, I investigated 
whether deletion of Frs2 in MEF cells can also prevent phospho-Crk stimulation. Frs2 
  
  
72 
deleted MEF cells were stimulated with bFGF for five minutes and similar to Shp2 it also 
prevented phospho-Crk stimulation. Interestingly, although there was no phospho-Crk 
stimulation the basal level phospho-Crk still remained in Frs2 deleted MEFs cells but not 
in Shp2 deleted MEF cells. This could be partly due to Shp2 having another important role 
in mediating Crk that may lead to the loss of the basal level of phospho-Crk.   
 
As mentioned previously, upon phosphorylation by a receptor tyrosine kinase, Frs2 has a 
docking site for Shp2 and other proteins such as Grb2 (Growth factor receptor bound 
protein 2).  The role of Grb2 in FGF signaling has been extensively studied and it has been 
established that upon FGF stimulation Frs2 binds to the Grb2/SOS complex to initiate 
downstream signaling (120). Therefore, it is possible that Grb2 could also interact with Crk 
to induce FGF mediated lens fiber cell elongation. To investigate this, I conditionally 
deleted Grb2 in MEFs using the adenovirus Cre . Grb2 deleted MEF cells did not have an 
effect on phospho-Crk but as expected showed a drastic decrease in phospho-ERK. These 
data taken together reveal a novel pathway in which Crk, Shp2, and Frs2 work together to 
initiate FGF mediated lens fiber cell elongation.   
 
3.2.3 Conditional Deletion of Rac1 in the Lens has a cell elongation defect 
It has been established that Ras and Rho GTPases play a significant role in cell adhesion, 
cell spreading, and cell shape (121)(122).  For example, Rap1 is a known Ras GTPase that 
is downstream of Crk and is targeted by the Crk SH3 binding domain guanine nucleotide 
exchange releasing factor C3G (123). In addition, activation of Rap1 is known to play a  
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Figure 21. The GTPase Rap1 is not essential for lens development and lens fiber cell 
elongation.  (A-C) H&E staining of the control lens, conditionally deleted Rap1a/Rap1b 
lens, and conditionally deleted Crk/CrkL at embryonic day 14. The Rap1depleted lens 
displayed a detachment of the lens fiber cells to the apical side of the lens epithelial layer. 
(A”-C’’) Smooth Muscle Actin (SMA) staining of the control lens, conditionally deleted 
Rap1a/Rap1b lens, and conditionally deleted Crk/CrkL at embryonic day 14. SMA was 
present in the lens epithelial layer of the Rap1 depleted lens (indicated by arrow) but not 
in the control lens or the Crk/CrkL depleted lens. 
A. A’’ 
B. B’’ 
C. C” 
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Figure 22. Conditional Deletion of Rac1 in the Lens has a cell elongation defect. (A-
B) Staining of the lens at embyronic day 14 with Rac1 antibody. Rac1 appeared completely 
deleted in the Rac depleted lens. (C-D) Staining of the Rac depleted lens with phospho-Erk 
antibody showed no significant difference in staining intensity. (E-H) Phalloidin (F-actin) 
staining of the control, deleted Rac1 (conditionally using the cre-lox system) and Rac2, 
conditionally deleted Crk and CrkL, and condtionally deleted Crk and CrkL in the 
presences of constitutively active Rac1 lens at embryonic day 14. Lens fiber cell length 
was measured to observe fiber cell length (indicated by arrows). (A’-F’) 
Immunohistochemistry staining of the Rac and Rap1 depleted lens with proliferation 
(Foxe3, E-cadherin, Ki67) and differentiation (C-Maf, Jagged 1,p57)  markers.  (I) Graph 
of relative fiber cell length. A student t-test was preformed on 3 different lens for each 
phenotype. 
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role in ERK activation and is also one of the main activators of the Integrin pathway (94). 
This motivated us to investigate whether deletion of Rap1 may also affect lens fiber 
elongation. Therefore, I conditionally deleted both Rap1a and Rap1b in the lens at 
embryonic day E14. The Rap1depleted lens had a slight reduction in size and displayed a 
defect in fiber cell attachment to the apical side of the lens epithelium (Figure 23. A-B). 
However, the Rap1depleted lens had none of the fiber cell elongation phenotypes observed 
in the Crk/CrkL mutant lens (Figure 23. B-C).  
 
Previously, it was found that the Rap1 mutant displayed a phenotype that altered the 
epithelial plasticity of the the Rap1mutant lens indictated by the presences of an epithelial 
to mesenchymal (EMT) biomarker SMA (smooth muscle actin) in the lens epithelial layer 
(97). I used this phenotype to further assess if the role of Rap1 in lens development is 
mediated by Crk/CrkL. As previously reported when Rap1 was conditionally deleted in the 
lens at embryonic day 14 and SMA was present in the lens epithelial layer. Interestingly, 
in the Crk and CrkL conditional knockout lens SMA was not present in the lens epthelial 
layer.  This data appears to rule out the idea that Rap1 has an essential component in lens 
development and lens fiber cell elongation. 
   
As mentioned previously, Rho GTPases are essential for cell adhesion and cell 
morphology. One of the main Rho GTPases that is essential for the above cellular processes 
is the GTPase Rac. Rac is an important downstream mediator of Crk signaling and is 
essential for cell adhesion, actin polymerization, lamellipodia extension, and 
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differentiation (98). Therefore, it is possible the Rac could also play a significant role in 
lens fiber cell elongation. To address whether or not Rac also play a role in lens fiber cell 
elongation, I observed the phenotype of the lens depleted of Rac1 and Rac2 isoforms 
together. Staining with a Rac1 antibody confirmed complete deletion of Rac1 in the Rac 
depleted lens (Figure 24 A-B). Unlike the conditionally deleted Crk and CrkL lens, the 
Rac1 deleted lens did not display a decrease in phospho-Erk (Figure 24. C-D). However, 
Rac deletion resulted a lens fiber cell elongation defect, albeit milder than that of deletion 
of Crk and CrkL in the lens (Figure 24. E-G). This data was also confirmed by statistical 
analysis of the lens fiber cell length (Figure 24. I). To further explore the role of Rac1 in 
lens fiber cell elongation I employed a constitutively active Rac1.  In the  presence of the 
constitutively active Rac1,  the Crk and CrkL conditional KO partially rescued the lens 
fiber cell defect. This data reveals a possible role of Rac1 in lens fiber cell elongation.  
 
It is clear that both Rac1 and Rap1 are downstream effectors of Crk and or CrkL and have 
two separate phenotypes. However, it is possible that Rac1 and Rap1 can partly compensate 
for each other during lens development and could mask the true phenotype. Therefore, we 
condtionally deleted both Rac and Rap1 in the lens at embryonic day 14. The Rac and Rap1 
lens was double stained with proliferation and differentiation markers to observe any 
changes that might have occurred as a result of both GTPases being deleted. Interestingly, 
deletion of both Rap1 and Rac1 in the lens had no additional phenotypes other than the 
phenotypes seen in both Rac and Rap1 alone. Deletion of both Rac1 and Rap1 seems to 
have an additive effect on the lens, displaying a phenotype similar to Rac1 alone with the 
addition of the apical attachment phenotype seen in the Rap1 mutant alone. There were 
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also no significant differences in the staining intensity or location for the proliferation and 
differentiation markers (Figure 24. A’-F’).  The relative fiber cell length also confirms that 
deletion of both Rac and Rap1 in the lens was still signifcantly larger than the Crk and 
CrkL deleted lens. There was also no difference in the relative lens fiber cell length 
comparing the Rac deleted lens to the Rac1 and Rap1 deleted lens (Figure 24. I).                          
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CHAPTER FOUR 
4.1 Discussion and Future Direction  
The role of FGF signaling in human development has been studied for many years because 
of the detrimental affect it has on fetal development during the gain or loss of function of 
FGF ligands and FGF receptors. For example, loss of the ligand FGF10 in the cause of 
Lacrimo-auriculo-dento-digital syndrome (LADD). LADD is an autosomal dominant 
disorder characterized by multiple phenotypes such as hypoplasia of the lacrimal and 
salivary gland, hearing loss, and dental anomalies (124). In addition , the loss of function 
of another ligand FGF3 is the cause of an autosomal recessive syndrome that causes 
congenital deafness due to a complete loss of  the inner ear structure (125). Although, loss 
of function mutations is common in FGF ligands, gain of function mutations can also occur. 
A gain of function mutation in FGF23 causes autosomal dominant hypophosphataemic 
rickets (ADHR).  Patients with ADHR have rickets due to the disruption of phosphate 
homeostasis caused by phosphate wasting (126).  
 
As mentioned previously, mutations in FGR receptors also contribute to multiple 
development disorders. For example, loss of function mutations in FGFR1 is the main 
cause Kallmann Syndrome (127). Named after the geneticist who discovered it, Kallmann 
syndrome is associated with patients not being able to reach puberty and usually lack the 
ability to sense smell. A gain of function mutations in FGFR2 is the main cause of 
craniosynostosis, which is described as the inability of the fibrous sutures in the skull to 
fuse properly. Lastly, a Gly380Arg point mutation in FGFR3 can promote non-covalent 
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interactions between transmembrane helices and is present in most cases of 
achrondroplasia, one of the most common genetic forms of dwarfism (128).    
 
To fully understand how the above disorders, mouse models have been one of the most 
useful tools in helping scientist understanding the role FGF signaling in human 
developmental disorders. For examples, a mouse model was generated for achrondroplasia 
by isolating the mouse FGFR3 gene and introducing a point mutation by changing Gly 
(GGG) to Arg (AGG) in codon 374 (the ortholog of human codon 380), which is located 
in exon 10. Mice with the Gly374Arg point mutation displayed a phenotype that was 
similar to that of the human Gly380Arg point mutation. Interestingly, mice homozygous 
for this mutation displayed kinky tails, exhibited overgrowth of the long bones, and 
contained a greatly expanded growth plate, unlike the heterozygous mice which only 
exhibited a form of dwarfism. Therefore, it was concluded that the expression of the 
achondroplastic phenotype depends on the expression of mature mRNA transcribed from 
the mutant allele. Using this same mouse model it was confirmed that achrondroplasia is 
caused by ligand-independent activation of the FGFR3 (129). Using models have also 
paved the way for understanding how to treat multiple genetic disorders like Huntington’s 
disease (HD). HD is a neurological disorder causes by a polyglutamine expansion in the N 
terminus of the protein huntingtin (Htt). It is known that FGF2 deficient mice display 
impaired neurogenesis (130). Therefore, FGF2 treatment was administered to an 
established HD mouse model. Treatment with FGF2 induced neurogenesis and expanded 
life of the HD mice (131). Therefore, creating mouse models is excellent source of 
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information for investigator when it comes to understanding and eradicating developmental 
diseases.   
  
Our laboratory and other laboratories have used mouse models to understand the FGF 
signaling pathway. In this study, I investigated the role of adaptor Crk and CrkL during 
FGF mediated lens development using various mouse models. The connection between 
Crk and CrkL and FGF signaling has been addressed, but not extensively. It is currently 
known that Crk is phosphorylated by the FGFR1 when it binds to tyrosine 463 which is 
dependent on FGF2 stimulation. It also understood that Crk is essential for FGFR-1 cell 
proliferation (68).  Studies have also revealed a role for CrkL in Digeorge syndrome and 
other human disorders. Using a CrkL and FGF8 knockout mouse model, it was found that 
they both genetically interact with each other and more importantly FGF8 can induce 
phosphorylation of FGF receptors and their binding to CrkL. These study have begun to 
address the role of Crk and CrkL in development, however the molecular mechanism is 
still not clear. Crk and CrkL both play an essential role in cell adhesion, cell morphology, 
cell spreading, etc. Most of the above cellular activities are connected to ability of Crk to 
mediate the Integrin pathway. I aimed to understand the molecular mechanism and cellular 
processes associated with the interaction between Crk/CrkL and the FGF receptor.        
 
To begin, I employed mouse genetics and conditional deleted Crk and CrkL in the mouse 
lens. The lens serves as a great model for studying cellular mechanisms and developmental 
processes due to its simplicity. The lens lacks blood vessels and is contains only one cell 
type that undergoes proliferation and differentiation to form the mature lens. In addition, 
the lens is derived from a single common cell called the lens precursor cell and will only 
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differentiate into lens epithelial cells and lens fiber cells which cause it to have a simple 
morphology. This simple morphology leads to the lens being one of the most useful organs 
to study developmental biology (12). One of the most valuable lens based studies was the 
establishment of the first line of transgenic mice that contained a tissue-specific promoter. 
In these particular studied it was a α-Crystallin promoter.  Crystallin is considered the main 
protein present in the ocular lens (132). Lens based studies have also been crucial in 
understanding multiple aspects of cancers. A recent studied done by Jean Jiang group used 
the lens to understand the role of connexins in cell growth, cell differentiation, and 
tumorgenesis. From this study it was found that connexins play a role in regulating cell 
cycle modulators and eventually cell growth and differentiation (133). 
 
Although the lens serves as a great model for studying developmental processes because 
its simplicity, there are some caveats to using the lens as a model. Using the lens as a model 
for development, scientist often run the risk of their data being lens specific when it comes 
to important cellular mechanism. An example of this is a study done by the Soriano lab in 
which they found the FGFR1 is mediated by Frs in some developmental contexts but other 
developmental processes like gastrulation and somitogenesis are controlled by FGFR1 
independent of Frs (67). So it is possible that in this study Crk/CrkL plays a role in FGF 
signaling during lens development but not in other developmental processes.  
 
There are also other organs that can serve as great models to study FGF signaling and 
development. FGF signaling has been implicated in being extremely important in heart 
development. To investigate how morphogenetic events are controlled by secreted 
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signaling, loss of function of FGFR1 and FGR2 in mouse was used to understand the role 
of FGF signaling in heart outflow tract development (134). This study is a great example 
of trying to understand signaling events using a mouse model and the heart as the organ of 
choice.  Another example of a great organ that’s used for study development is the 
development of the inner ear. In a mice that contained a null FGF3 and hypomorphic FGF8 
fail to undergo otic induction. Indicating the importance of  FGF signaling in otic induction 
(135). Lastly, FGF signaling is essential for another rigid organ called bone. FGF signaling 
has been studied many years for its role in skeletal development making it a great model 
to study developmental processes. A recent study was done to understand the role of FGF18 
in autophagy. Chondrocyte autophagy is essential for bone growth. Chondrocytes are 
related to bone in that they are embedded in cartilage and secrete the matrix for cartilage. 
Cartilage is the essential connective tissue found in between bones. From this study it was 
found that FGF18 is a regulator of chondrocyte autophagy which was observed by mice 
lacking FGF18. The mice that lacked FGF18 displayed low levels of chondrocyte 
autophagy compared to wild type mice (136).  
 
In addition to there being multiple organs that could have been use to study development 
and FGF signaling there are multiple model organisms that could have been used to 
investigate FGF signaling. In particular, there are other organisms that could have been 
used to study eye development. One widely used organism other than mice is the zebrafish. 
Zebrafish have been used to study eye development for many years. Similar to mice 
zebrafish exhibit multiple characteristic that make it a great model for studying 
development including the large number of offspring, its rapid embryonic growth, and 
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transparency of its embryos. When it comes to eye development in the zebrafish, the eye 
and retina are visually oriented similar to humans. This allows scientist to study the ocular 
development and various diseases of the eye (137).  A recent study investigated the role of 
melanosomes in zebrafish lens development. Albino zebrafish, that completely lack 
melanosomes, developed abnormal lens reflection and increased oxidative stress. 
Suggesting that melanosomes in pigmented epithelial cells play a major role in protecting 
the lens from oxidative stress (138). Zebrafish have also been used to investigate the 
earliest development of the lens, as early as the pre-placodal cells. Zebrafish were used in 
identifying pre-placodal cells using cell-tracing experiments (139).   
 
There is also another model organism that has been used frequently which is the drosophila 
melanogaster or the fruit fly. The compound eyes of the drosophila have been used to study 
various cellular activities including cell proliferation, differentiation, polarization, and 
migration. In addition, the drosophila has been use for understand multiple human diseases 
such as cancer and neurodegenerative disorders (140).  There are several drosophila cancer 
models that have been established to understand metastasis. The Shearn group used an 
allograft experiment to understand the role lgl and brat in tumor metastasis. Metastic 
tumors mutant larvae where allograft into the abdomen of wild type adult drosophila. This 
resulted in rapid tumor and was the first evidence of  proving that scientist are able to use 
drosophila to study metastasis (141).  
 
As mentioned early drosophila has been a great model organism for understanding 
neurodegenerative disease. Alzheimer’s diseases (AD) have been one of the main 
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neurodegenerative disease that has been investigated using a drosophila model. More 
importantly, most of the genes associated with AD have a drosophila homolog. The 
Amyloid Precursor Protein (APP) has a drosophila homolog APPL (APP-like). Drosophila 
with the APPL deleted displayed abnormal behavior and could be resued by a human APP 
transgene (142). Lastly, drosophila has been a great model for scientist who study the 
development of the eye.  Drosophila has been used to investigate targets for Pax6 to carry 
out the function of eye development because although the structure of the drosophila eyes 
is very different from vertebrates, the molecular mechanism underlying eye pattern is 
similar. Therefore, it was established that drosophila could be used to study mammalian 
ocular development (143).  
 
Lastly, chick embryos have been implicated as a great model in studying eye development. 
Similar to mice and drosophila, the chick embryo is an excellent model because of rapid 
development and its ability to be easily manipulated for experimentation. In particular 
chick embryos have mainly been used to understand the retina and retina development. For 
example, the chick embryo has been used to investigate the molecular mechanism 
responsible for retina regeneration. The chick embryo lends itself as a great model for 
studying retina regeneration mainly because of how accessible the embryo is for 
microsurgery and the ability of the retina to be replaced if damaged (144).  
 
The chick embryo has also been used to investigate the formation of the ciliary body. It 
was found that FGF is responsible for mediating the induction of the ciliary body in the 
eye of the chick embryo (145). Lastly, the chick has been used to study lens development. 
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Specifically, using the lens of the chick embryo it was found that all pre-placodal cells are 
specified as lens, until FGF expressed in migrating neural crest cells leading leads to the 
promotion of the olfactory fate (146). Therefore, the chick would have also been a great 
model to use for this study. However, our established mouse models was an excellent 
choice for this study.  
 
In this study, I demonstrated that during lens development Crk and CrkL individual 
mutants did not have a severe phenotype and these two protein could compensate for each 
other. The thought that  Crk and CrkL can compensate for each other as been controversial. 
Although the homology between Crk and CrkL is similar in terms of the SH2 and SH3 
domain they have distinct roles in multiple cellular processes. In addition, mice that have 
either Crk or CrkL deleted systemically die but from very different causes (53). In 
embryonic fibroblast cells that have Crk II deleted, CrkL was not overexpressed, indicating 
that there is no compensation by CrkL. This was also evident for cells that have CrkL 
deleted (147). There is also evidence that Crk and CrkL can compensate for each other. 
Crk adaptors have been implicated in playing a role in the reelin pathway. Stimulation of 
the reelin pathway enhances dendritogenesis in the hippocampal neurons of mice in a Src 
dependent manner. It was found that this stimulation was only blocked by decrease 
expression of both Crk and CrkL. Indicating that Crk and CrkL can compensate for each 
other during dendritogenesis (148). 
 
 However, deletion of both Crk and CrkL in the lens results in a severe phenotype 
consisting of defects in lens morphology, cell proliferation, cell adhesion, the extra-cellular 
matrix, and cell elongation. However, one of the most striking phenotypes in this study 
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was the rotation of the lens epithelium caused by the deletion of Crk and CrkL in the lens.  
How or why Crk and CrkL is causing the rotation of lens epithelium hasn’t been addressed. 
There are several theories that could explain this phenotype. One theory could be that Crk 
and CrkL plays an important role in planar cell polarity. Planar cell polarity is the 
polarization of cells with in the plane of a cell sheet and is essential for the function of 
multiple biological processes. In particular, planar cell polarity is mostly seen in epithelial 
tissues in which cells within an epithelium often display polarity across the plane of the 
epithelium (149). To investigate whether disruption of the planar cell polarity is the cause 
of the lens epithelium rotation immunohistochemistry could be perform on the Crk and 
CrkL knockout lens with planar cell polarity markers such as c-Jun terminal kinase (JNK) 
which is known to be downstream of the GTPases Rac and Rho in the β-catenin 
independent planar cell polarity pathway (150). Other possible markers can include 
disheveled 1/2/3, and Daam-1, both key factors in the planar cell polarity pathway.  
 
Another reason that the lens epithelium is rotated in the Crk and CrkL knockout lens could 
be because the lens epithelial cells have a cell migration defect. Specifically, lens epithelial 
cells may not be able to migrate properly and completely form the lens epithelium. Crk 
activated Rac is important for the formation of membrane protrusions by actin 
polymerization during cell migration (151).  To investigate this a scratch assay and or an 
in vitro cell migration assay can be done using lens epithelial cells such as TN4α, 
presumable with Crk and CrkL knockdown in these cells.   
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Deletion of Crk and CrkL also attenuated a gain-of-function phenotype caused by 
overexpression of FGF3. The gain-of-function phenotype, seen in the lens by the 
overexpression of FGF3, was first discovered by Micheal Robinson’s group on their quest 
to find the role of FGFs and FGF receptors during lens development. It was shown that the 
overexpression of FGF3 in the developing lens of transgenic mice, driven by a αA-
crystallin promoter, caused abnormal cell elongation and differentiation of lens epithelial 
cells. The phenotype of embryos beginning at E12.5 also consisted of ocular proptosis and 
eventually the rupturing of the cornea (44). Taking advantage of this unique phenotype our 
laboratory recently addressed the role of heparan sulfates in FGF signaling during lens 
development. Disruption of Ndst-mediated heparan sulfate modifications led to a small 
lens and attenuation of phospo-ERK, indicating the down regulation of FGF signaling. 
Interestingly, the overexpression of FGF3 in the embryonic lens leads to ERK hyper-
phosphorylation. However, in an embryonic lens with both the deletion of Ndst and 
overexpression of FGF3, the ERK hyper-phosphorylation was decreased and abnormal 
differentiation of lens epithelial cells was abolished. These results indicate that the Ndst 
mutation is epistatic to FGF3 overexpression and the function of Ndst is essential for FGF3 
signaling during lens development (46). Using this same approach our lab was the first to 
show that Crk and CrkL is also important for FGF3 mediated lens development indicated 
by the decrease in ERK hyper-phosphoryation and loss of abnormal differentiation in the 
embryonic lens. However, the question of whether or not the activity of Crk and CrkL is 
specific to the FGF3 still remains. There is another transgenic mouse that was developed 
by Micheal Robinson and colleagues, that overexpresses human FGF1 in the developing 
lens. Similar to the overexpression of FGF3, at embryonic day 15 the lens exhibited 
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abnormal lens epithelial cell elongation, lens vacuolization, and cataract. Therefore, it 
would be interesting to see if deletion of Crk and CrkL could attenuate the phenotype 
displayed by the overexpression of FGF1.  
 
Deletion of Crk and CrkL in the lens led to a decrease in activity of the downstream effector 
ERK. This data is not surprising in that it has been shown that deletion of Crk in MEF cells 
show a decrease in ERK activity in the presences of FGF8 (69). However, it would be 
interesting to see what happens if ERK is conditional deleted in the lens. It is expected that 
conditional knockout of ERK in the lens would have a cell elongation defect similar to the 
Crk and CrkL knockout lens. However, it is also possible that the activation of ERK by 
Crk is not important for lens fiber cell elongation but could be important for other cellular 
processes like cell proliferation. In this study I did show that deletion of Crk and CrkL in 
the lens led to a decrease in lens epithelial cell proliferation.  
 
The deletion of Crk and CrkL could be rescued by constitutively active Kras. It is not 
surprising that Crk and CrkL can interact with Ras. However, what is surprising is the fact 
tha Crk and CrkL is upstream of Ras during FGF mediated lens fiber cell elongation. The 
Crk adaptor proteins are known to be upstream of various GTPases so to reveal specifically 
that it is upstream of Ras during lens fiber cell elongation is novel. Also, deletion of Crk 
and CrkL in the lens displayed several phenotypes that could not be rescued by the 
constitutively active Kras such as the rotation of the lens epithelium, defects in the 
extracellular matrix, and abnormal cell adhesion. This data suggests the idea that the Crk 
and CrkL have additional roles in lens development independent of Ras signaling pathway. 
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Crk and CrkL have been extensively studied for its role in the Integrin pathway. Crk and 
CrkL are responsible for integrin mediated cell adhesion, actin polymerization, cell 
migration, and cell polarity (52,55). The known roles of Crk and CrkL in Integrin signaling 
is consistent with the phenotypes seen in Crk and CrkL mutant lens, explaining why these 
phenotypes could not be rescued by Kras.   
 
The involvement of Crk and CrkL in multiple processes made it imperative that in this 
study I narrowed down the role of Crk and CrkL in lens development. Lens fiber cell 
differentiation is a large part of lens development and is essential for the function of the 
lens. What is very interesting is how Crk and CrkL can control ERK activity but have no 
effect on differentiation. Especially since lens fiber cell differentiation is characterized by 
lens fiber cell elongation and ERK is essential for lens fiber cell differentiation (152). This 
is could be possible, through a mechanism in which Crk and CrkL are recruited to the FGF 
signaling pathway after lens fiber cell differentiation to promote lens fiber cell elongation. 
This is possible because when Crk and CrkL  is  deleted in the lens, the lens fiber cell 
differentiation isn’t affected indicated by the abundant staining intensity  of  multiple 
differentiation markers.  
Concerning the regulation of Crk adaptor proteins in FGF signaling during lens 
development, Crk activity is surprisingly controlled by the phosphatase Shp2, indicated by 
the loss of phospho-Crk when Shp2 is deleted in MEF cells. However, how exactly Crk 
and CrkL interact with Shp2 is still not understood. Therefore, to further confirm the 
interaction with Shp2 and Crk it would be interesting to know what are the specific binding 
sites of Crk and CrkL on Shp2. Shp2 has two tyrosine phosphorylation sites Tyr-542 and 
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Try-580 that are known to activate ERK in FGF stimulated MEF cells (153). It would be 
nice to explore whether or not mutations of both of these tyrosine phosphorylation sites on 
Shp2 in MEF cells cause a decrease in the activation of Crk similar to the loss of observed 
in this study when Shp2 was deleted in MEF cells. A caveat to this is that Crk and CrkL 
may not directly bind to Shp2 but could bind to another protein downstream or upstream 
of Shp2. Proteins such as Grb2 are known to interact with Shp2 to activate downstream 
Ras. In a recent study to identify CrkL binding proteins in myotubules using a tagged form 
of CrkL and spectrometric analysis,  Grb2 was ranked number eight in the a group of sixty-
one proteins that are considered the most abundant proteins bound to CrkL in myotubules 
(154). Therefore, Grb2 is a strong candidate for the connection between Crk and Shp2 in 
FGF mediated cell elongation. However, deletion of Grb2  in MEF cells reveal that when 
stimulated with FGF there is no significant differences in phospho-Crk between wild type 
MEF cell and the Grb2 deleted MEF cells. This supports the idea that Shp2 could directly 
binds to Crk. 
 
However, there is a candidate protein that could be upstream of Crk and CrkL in addition 
to Shp2, called Frs2.  Frs2  is a docking protein that is responsible for the recruitment of 
multiple molecules to the FGF receptor (155). In addition, our lab has shown that deletion 
of both Shp2 and Frs2 in the lens causes a severe defect in the lens compared to either alone 
(48).  This study also shows that phospho-Crk was not stimulated by FGF2 in Frs2 deleted 
MEF cells.  Therefore, it would be interesting to investigate the genetic interactions 
between Crk, CrkL, and Frs2. Conditional deletion of all three molecules in the lens could 
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further explain whether or not they interact indicated by a more severe phenotype than Crk 
and CrkL alone and loss of downstream FGF effectors such as phospho-ERK.  
 
The idea that Shp2 can heavily control the activity of Crk promotes the idea that Shp2 is 
really important for lens fiber cell elongation and deletion of Shp2 alone in the lens would 
produce a phenotype similar to the Crk and CrkL deleted lens. It is important to note that, 
Shp2 has been known to play an important role in Focal Adhesion (FA) formation and cell 
morphology (156). It would also be a great idea to take advantage of cell biology techniques 
by observing cell morphology and focal adhesion in Shp2 deleted MEF cells. The cells 
could also be stained with proteins that are known to be in the focal adhesion complex such 
as phospo-Paxillin and Integrin.   
 
Crk and CrkL are known to activate other GTPases such as Rac1 and Rap1 to induce 
downstream signaling. In my study, conditional deletion of both Rac and Rap1 in the lens 
displayed phenotypes less severe than Crk and CrkL mutant lens. It is unlikely that Rap1 
is downstream of FGF signaling because it does not have any of the Crk and CrkL mutant 
lens phenotypes such as a defect in cell elongation. In addition, the Crk and CrkL mutant 
lens doesn’t display the key phenotypes seen in Rap1 mutant lens. This is definitely 
possible because Rap1 is important for regulating the ERK/Ras pathway possible by 
trapping Raf in an active complex thereby inhibit ERK activation. ERK activity would still 
be functional when Rap1 is deleted which why I might not  see the lens fiber cell elongation 
defect seen in the Crk and CrkL condtional knockout lens. This could also mean that 
deletion of Rap1 in the lens could rescue the Crk and CrkL deleted phenotype.   
  
  
92 
 
What is definite is that Rap1 does play a significant role in lens development (97). In our 
laboratories quest to investigate lens development it would interesting to find another novel 
pathway in which Rap1 is important for other cellular processes that are related to is 
phenotype like cell adhesion. Although, the role of Crk in Rap1 signaling has been 
extensively investigate that are other stimulators or environmental factors that could 
activate Rap1 during lens development (157).  On the other hand, although less severe, 
Rac1 mutant lens does have a cell elongation defect and exhibits a reduction in lens size 
similar to Crk and CrkL mutant lens. Previous studies done by the Rao group show that 
growth factor can induce activation of Rho and Rac GTPases in human lens epithelial cells 
(101). It would be interesting to see if the Rac mutant lens could be rescued by Kras. 
Notably, Lambert and colleagues recently showed that the guanine nucleotide exchange 
factor Tiam mediates Ras activation of Rac during PI3K signaling (158).  
 
I also employed a constitutively active Rac1 to see if the Crk and CrkL deleted lens fiber 
cell elongation defect could be rescued. It is clear that the Crk and CrkL lens fiber cell 
elongation defect could partly be rescued but not fully. This was also true in the presences 
of a constitutively active Kras. This indicates that both of these GTPases are essential for 
lens fiber cell elongation. What isn’t clear is the cellular mechanism. Are they both control 
by the FGF signaling pathway? To answer this question there is a plethora of experiments 
that could be done. I could first see if Ras could rescue the the Rac1 conditional deleted 
lens phenotype. This was possible because as mentioned previously Ras can activate Rac. 
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It would also be important to create a mouse model with the Crk and CrkL conditional 
knockout lens in the presences of both the constitutively activate Kras and Rac. 
 
Once Crk and CrkL is activated our study predicts the binding of a GEF to Crk and CrkL 
leads to the activation of the GTPases Ras. The GEF that leads to GTPase activation in our 
novel pathway is unknown. Crk and CrkL is known to bind to several GEF including C3G, 
DOCK180, and SOS. Knowing the GEF that is responsible for Ras activation could add to 
the specificity of the proposed pathway. Conducting a Co-Immunoprecipation assay with 
Crk/CrkL and the GEFs above would be the possible approach to answering this question.  
Specifically, this study has confirmed that the FGF signaling pathway is mediating lens 
fiber cell elongation with the help of Crk and CrkL. However, we cannot rule out the 
possible of crosstalk between the FGF signaling pathway and the integrin pathway. Crk 
and CrkL are essential for integrin signaling and plays a role in cell morphology, cell 
adhesion, cell migration, etc (65). Although in the presences of a constitutively active K-
ras, the lens size and elongation defect of the Crk and CrkL knockout lens was rescued but 
it still wasn’t complete rescued compared to wild type. This opens up ideas for the 
involvement of other pathways, like the integrin pathway, in lens fiber cell elongation. 
Contributing to this idea conditional deletion of Rac in the lens showed a phenotype similar 
to Crk and CrkL. Rac is known to be downstream of the Integrin pathway and is activated 
when Crk binds to the GEF DOCK180 (53). Thus, the idea that the Integrin pathway could 
be contributing to lens fiber cell elongation should be explored possible through deletion 
of the various Integrin’s that are expressed in the lens. The proposed experiment would be 
to observe if there is a cell elongation defect when Integrin is deleted in the lens.  
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Lastly, data from this study strongly supports the role of Crk and CrkL in FGF mediated 
lens fiber cell elongation. To support this theory in vitro studies using lens epithelial 
explants is worth exploring.  Using lens epithelium explants will give us the opportunity to 
observe lens fiber cell elongation in the presence of FGF in wildtype and Crk and CrkL 
knockout lens epithelial explants. It is expected that in the presences of FGF the wild type 
lens epithelial cells in the explant will differentiate into lens fiber cells and elongate. On 
the other hand, in the Crk and CrkL knockout lens explant, the epithelial cells will maintain 
their cuboidal shape and not elongate in the presences of FGF. Immunocytochemistry with 
epithelial and differentiation markers will confirm the differentiation of epithelial cells to 
lens fiber cells. Lens fiber cell length would also be quantified. In conclusion, data from 
this studies strongly support a novel pathway that is important for mediating lens fiber cell 
elongation, a mechanism that has not be extensively explored until now. However, there 
are still multiple experiments that can be done to support this study.    
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CHAPTER FIVE 
5.1 Summary  
Cell shape is essential to the function of multiple cells types and is associated with multiple 
disease such as sickle cell disease and cancer. Patients with sickle cell disease present with 
abnormal shaped red or sickled blood cells that is caused by a mutation in the hemoglobin 
gene. This cell shape change causes red blood cells to stick to the wall of the blood vessel 
and lead to a blockage in blood flow preventing the distribution of oxygen to multiple 
tissues. Along these same lines, changes in cancer cell morphology due to environmental 
cues is associated with tumor metabolism and or metastasis spreading. Therefore, it is 
imperative that the molecular mechanism behind cell shape changes is fully understood.  
 
Cell shape plays a major role in the development of the lens during lens fiber cell 
elongation. During lens development, lens epithelial cells will migrate down from the 
germinative zone of lens, differentiate into lens fiber cells and elongate along the anterior 
and posterior of the lens. The elongation of the lens fiber cell is an important cell shape 
change that is valuable for the development of the lens. However, the molecular mechanism 
that controls this is poorly understood. The FGF signaling pathway is required for lens 
development but its involvement in lens fiber cell elongation is not clear. In addition, 
adaptor Crk and CrkL are likely candidates for mediating cell elongation because of their 
known roles in cell adhesion, cell migration, and cytoskeleton reorganization. 
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Therefore, in this study we investigated the role of adaptor proteins Crk and CrkL in FGF 
signaling during lens development. We employed the cre-lox system to conditional delete 
Crk and CrkL in the lens. At E14 the lens had a severe phenotype consisting of a small 
lens, rotation of lens epithelium, and disorganization of the lens fiber cells. Immunostaining 
with the proliferation marker Ki67 revealed a decrease in proliferating cells indicating a 
cell proliferation defect. TUNEL analysis also showed an increase in cell apoptosis which 
partly explains the small lens phenotype. The Crk and CrkL knockout lens also displayed 
a defect in cell adhesion and the extracellular matrix indicated by loss in prominent cell 
adhesion and cell membrane markers such as paxillin and collagen, respectively.  
 
To confirm a role of Crk and CrkL in FGF signaling during lens development I stained the 
Crk and CrkL knockout lens with activated Erk (phospho-Erk), a downstream effector of 
the FGF signaling pathway. There was a clear reduction of phospho-Erk in the knockout 
lens compared to wild type. To support this data using western blot analysis, deletion of 
Crk and CrkL in MEF cell stimulated with FGF2 had a decrease in phospho-Erk.  In 
addition, Crk and CrkL is epistatic to the FGF receptor and the lens size and cell elongation 
defect in the Crk and CrkL mutant lens could be rescued by a constitutively active K-Ras. 
Data from this study also showed that during lens development cell elongation is 
independent of differentiation.   
 
To observe whether there is a synergistic relationship between Crk and other proteins 
downstream of the FGF receptor, Crk, CrkL, and the phosphatase shp2 was conditionally 
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deleted in the lens. Loss of all three molecules exhibited a complete loss of phospho-Erk 
in the lens. This data along with loss of phospho-Crk in Shp2 deleted MEF cells stimulated 
with FGF2 shows that Shp2 can control Crk activity during FGF signaling. Lastly two 
GTPases, Rac and Rap1 that are known to be downstream effectors of Crk and CrkL were 
analyzed for their role in lens fiber cell elongation. Conditional deletion of Rac and Rap in 
the lens exhibited a very different phenotype in the lens, with Rac having a phenotype 
similar to the Crk and CrkL mutant lens. Rap however, had a less severe phenotype 
compared to Crk and CrkL consisting of a slightly smaller lens and disruption in the 
attachment of the apical end of lens fiber cells to the lens epithelium. Although Rap1 is 
excluded for being involved in lens fiber cell elongation, Rac is still under investigation do 
to its similarities to Crk and CrkL when its deleted in the lens. Therefore, this data taken 
together reveals a novel Crk-Shp2-Ras pathway important for FGF mediated lens fiber cell 
elongation. 
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